Embodiments are described herein that relate to devices and methods for use in the delivery and deployment of prosthetic valves, and particularly to devices and methods for prosthetic heart valves that provide for delivery of the prosthetic heart valves to within a heart of a patient in an inverted configuration.
Prosthetic heart valves can pose particular challenges for delivery and deployment within a heart. Valvular heart disease, and specifically, aortic and mitral valve disease is a significant health issue in the United States (US); annually approximately 90,000 valve replacements are conducted in the US. Traditional valve replacement surgery involving the orthotopic replacement of a heart valve is considered an “open heart” surgical procedure. Briefly, the procedure necessitates surgical opening of the thorax, the initiation of extra-corporeal circulation with a heart-lung machine, stopping and opening the heart, excision and replacement of the diseased valve, and re-starting of the heart. While valve replacement surgery typically carries a 1-4% mortality risk in otherwise healthy persons, a significantly higher morbidity is associated to the procedure largely due to the necessity for extra-corporeal circulation. Further, open heart surgery is often poorly tolerated in elderly patients. Thus elimination of the extra-corporeal component of the procedure could result in reduction in morbidities and cost of valve replacement therapies could be significantly reduced.
While replacement of the aortic valve in a transcatheter manner is the subject of intense investigation, lesser attention has been focused on the mitral valve. This is in part reflective of the greater level of complexity associated to the native mitral valve apparatus, and thus, a greater level of difficulty with regards to inserting and anchoring the replacement prosthesis. A need exists for delivery devices and methods for transcatheter mitral valve replacements.
Some known delivery methods include delivering a prosthetic mitral valve through an apical puncture site. In such a procedure, the valve is placed in a compressed configuration within a lumen of a delivery catheter of, for example, 34-36 Fr (i.e. an outer diameter of about 11-12 mm). Delivery of a prosthetic valve to the atrium of the heart can be accomplished, for example, via a transfemoral approach, transatrially directly into the left atrium of the heart, a jugular approach or transapically. In many cases, it is desirable for the prosthetic valve to have a small outer perimeter or profile to allow insertion through a smaller delivery catheter of, for example, 28 Fr (i.e. an outer diameter of about 9 mm).
Thus, a need exist for prosthetic heart valves that can have a small profile during delivery while still maintaining the size and characteristics needed to perform their desired function within the heart.
A need also exists for devices and methods for delivering and deploying a prosthetic heart valve within a heart, with the valve disposed within a small diameter delivery sheath and then moving the valve to an expanded configuration within the heart.
Apparatus and methods are described herein for various embodiments of a prosthetic heart valve, delivery apparatus and delivery methods for delivering a prosthetic heart valve to a heart of a patient via a transvascular and a transapical delivery approach. In some embodiments, a prosthetic heart valve includes an outer frame coupled to an inner frame and the outer frame is movable between a first configuration relative to the inner frame and a second inverted configuration relative to the inner frame. The valve can be delivered to a heart using an apparatus that includes a delivery sheath that defines a lumen that can receive the prosthetic heart valve therein when the outer frame is in the inverted configuration. Actuation wires are releasably coupled to the outer frame and can be used to help revert the outer frame after the valve is deployed outside of the delivery sheath and within the heart.
Apparatus and methods are described herein for prosthetic heart valves, such as prosthetic mitral valves, that can be configured to be moved to an inverted configuration for delivery of the prosthetic valve to within a heart of a patient. As described herein, in some embodiments, a prosthetic valve includes an outer frame that can be inverted relative to an inner frame when the prosthetic valve is in a biased expanded configuration. The prosthetic mitral valve can be formed with, for example, a shape-memory material. After inverting the outer frame, the prosthetic valve can be inserted into a lumen of a delivery sheath such that the prosthetic valve is moved to a collapsed configuration.
The delivery sheath can be used to deliver the prosthetic valve to within a patient's heart using a variety of different delivery approaches for delivering a prosthetic heart valve (e.g., prosthetic mitral valve) where the inverted prosthetic valve would enter the heart through the atrium of the heart. For example, the prosthetic valves described herein can be delivered using a transfemoral delivery approach as described in PCT International Application No. PCT/US15/14572 (the “572 PCT application”) and/or in PCT International Application No. PCT/US16/12305 (the “'305 PCT Application”), each disclosure of which is incorporated by reference in its entirety herein, or via a transatrial approach, such as described in U.S. Provisional Patent Application Ser. No. 62/220,704, entitled “Apparatus and Methods for Transatrial Delivery of Prosthetic Mitral Valve,” filed Sep. 18, 2015 (the “'704 provisional application”), which is incorporated herein by reference in its entirety. In another example, the prosthetic valves described herein (e.g., an inverted valve as described herein) could be delivered via a transjugular approach, e.g., via the right atrium and through the atrial septum and into the left atrium, as described in U.S. Provisional Patent Application Ser. No. 62/305,678, entitled “Apparatus and Methods for Delivery of Prosthetic Mitral Valve,” (the “'678 provisional application”) and in U.S. Patent Application Pub. No. 2017/0079790, entitled “Apparatus and Methods for Delivery of Prosthetic Mitral Valve,” (the “'790 publication”) each incorporated by reference in its entirety herein. The prosthetic valves described herein can also be delivered apically if desired. With a transapical approach, after the delivery sheath has been disposed within the left atrium of the heart, the prosthetic mitral valve is moved distally out of the delivery sheath such that the inverted outer frame reverts and the prosthetic valve assumes its biased expanded configuration. The prosthetic mitral valve can then be positioned within a mitral annulus of the heart.
In some embodiments, an apparatus includes a delivery sheath that defines a lumen, an elongate member that defines a first lumen and a second lumen and is at least partially disposed within the lumen of the delivery sheath. The apparatus further includes a prosthetic heart valve disposed at least partially within the lumen of the delivery sheath in a collapsed configuration and circumferentially about a portion of the elongate member. The prosthetic heart valve includes an outer frame coupled to an inner frame. The outer frame is movable between a first configuration relative to the inner frame and a second configuration relative to the inner frame in which the outer frame is inverted relative to the inner frame. The prosthetic heart valve is disposed within the lumen of the delivery sheath with the outer frame in the second configuration and disposed axially proximal to the inner frame. The apparatus further includes a first actuation wire releasably coupled to a first portion of the outer frame and routed from the first portion through the first lumen of the elongate member and out a proximal end portion of the delivery sheath. The apparatus further includes a second actuation wire releasably coupled to a second portion of the outer frame and routed from the second portion through the second lumen of the elongate member and out the proximal end portion of the delivery sheath. The first portion and the second portion of the outer frame are configured to be disposed within an atrium of a heart when implanted within the heart.
In some embodiments, a method includes inserting a distal end portion of a delivery sheath through an apical region of a heart and into an atrium of the heart. The delivery sheath has a prosthetic heart valve disposed within a lumen of the delivery sheath. The prosthetic heart valve includes an outer frame and an inner frame coupled to the outer frame. The outer frame is movable between a first position relative to the inner frame and a second position relative to the inner frame in which the outer frame is inverted relative to the inner frame. The prosthetic heart valve is disposed within the lumen of the delivery sheath with the outer frame in the second position relative to the inner frame during the inserting. The method further includes moving the prosthetic heart valve distally out of the delivery sheath. The method further includes causing the outer frame of the prosthetic heart valve to transition to the first position relative to the inner frame such that the prosthetic heart valve at least partially assumes a biased expanded configuration. The method further includes positioning the prosthetic heart valve within an annulus of the heart.
In some embodiments, a method includes inserting a distal end portion of a delivery sheath into an atrium of a heart. The delivery sheath has a prosthetic heart valve disposed within a lumen of the delivery sheath. The prosthetic heart valve includes an outer frame and an inner frame coupled to the outer frame. The outer frame is movable between a first position relative to the inner frame and a second position relative to the inner frame in which the outer frame is inverted relative to the inner frame. The prosthetic heart valve is disposed within the lumen of the delivery sheath with the outer frame in the second position relative to the inner frame and disposed at least partially axially proximal to the inner frame during the inserting. The method further includes moving the prosthetic heart valve distally out of the delivery sheath. The method further includes causing the outer frame of the prosthetic heart valve to transition to the first position relative to the inner frame such that the prosthetic heart valve at least partially assumes a biased expanded configuration. The method further includes positioning the prosthetic heart valve within an annulus of the heart.
In some embodiments, an apparatus includes an outer sheath that defines a lumen, a delivery sheath that defines a lumen and is movably disposed within the lumen defined by the outer sheath, and a prosthetic heart valve disposed within the lumen of the delivery sheath in a collapsed configuration. The prosthetic heart valve includes an outer frame coupled to an inner frame. The inner frame is removably coupled to a distal end portion of a valve holder. The outer frame is movable between a first configuration relative to the inner frame and a second configuration relative to the inner frame in which the outer frame is inverted relative to the inner frame. The prosthetic heart valve is disposed within the lumen of the delivery sheath with the outer frame in the second configuration. The apparatus further includes a first actuation wire releasably copuled to a first portion of the outer frame, and a second acutation wire releasably coupled to a second portion of the outer frame. Each of the first acutation wire and the second acutation wire has (1) a first portion extending proximally from the outer frame, through the lumen of the outer sheath, along an outside wall of the delivery sheaht, and through a first side aperture defined by the delivery sheath, and (2) a second portion extending proximally from the outer frame, through the lumen of the outer sheaht, along the outside all of the delivery sheaht, and through a second side aperture defined by the delivery sheath. The first portion and the second portion of each of the first acutation wire and the second acutation wire are configured to be pulled proximally to urge the outer frame from the second configuration towards the first configuration relative to the inner frame.
In some embodiments, an apparatus includes a prosthetic valve that includes an inner frame and an outer frame coupled to the inner frame at multiple coupling joints. The multiple coupling joints are configured to allow the outer frame to be moved relative to inner frame such that the prosthetic valve can be moved between a first configuration and a second configuration. The outer frame and the inner frame collectively define a first length of the prosthetic valve when the prosthetic valve is in the first configuration and a second length of the prosthetic valve when the prosthetic valve is in the second configuration and the second length is greater than the first length. The inner frame has a length that is the same when the prosthetic valve is in both the first configuration and the second configuration.
In some embodiments, an apparatus includes a prosthetic heart valve that includes an inner frame and an outer frame coupled to the inner frame at multiple coupling joints. The prosthetic valve is movable between a first configuration and a second configuration. The multiple coupling joints are configured to allow the outer frame to be moved between a first position relative to the inner frame and a second position relative to inner frame in which the outer frame is inverted relative to the inner frame. The prosthetic valve is in the first configuration when the outer frame is in the first position, and in the second configuration when the outer frame is in the second position.
In some embodiments, an apparatus includes a prosthetic heart valve that includes an inner frame, and an outer frame coupled to the inner frame at multiple coupling joints. The multiple coupling joints are configured to allow the outer frame to be moved relative to inner frame such that the prosthetic valve can be moved between a first configuration and a second configuration. The outer frame has an outer frame coupling portion coupled to the inner frame at multiple coupling joints and an outer frame free end portion. The inner frame has an inner frame coupling portion coupled to the outer frame at the multiple coupling joints. A first end portion and an inner frame free end portion are on an opposite end of the inner frame from the first end portion. The multiple coupling joints are disposed between the outer frame free end portion and the first end portion of the inner frame when the prosthetic valve is in the first configuration. The multiple coupling joints are disposed between the inner frame free end portion and the outer frame free end portion when the prosthetic valve is in the second configuration.
In some embodiments, an apparatus includes a prosthetic heart valve that includes an inner frame coupled to an outer frame at multiple coupling joints. The multiple coupling joints are configured to allow the outer frame to be moved relative to inner frame such that the prosthetic valve can be moved between a first configuration and a second configuration. The outer frame has an outer frame coupling portion coupled to the inner frame at the multiple coupling joints and an outer frame free end portion. The inner frame has an inner frame coupling portion coupled to the outer frame at the multiple coupling joints and an inner frame free end portion. The outer frame free end portion and the inner frame free end portion each open in the same direction when the prosthetic valve is in the first configuration. The outer frame free end portion and the inner frame free end portion open in opposite directions when the prosthetic valve is in the second configuration.
In some embodiments, an apparatus includes a delivery sheath that defines a lumen, a valve holder movably disposable within the lumen of the delivery sheath and a prosthetic heart valve disposed at least partially within the lumen of the delivery sheath in a collapsed configuration. The prosthetic heart valve includes an outer frame coupled to an inner frame and the inner frame is removably coupled to a distal end portion of the valve holder. The outer frame is movable between a first configuration relative to the inner frame and a second configuration relative to the inner frame in which the outer frame is inverted relative to the inner frame. The prosthetic heart valve is disposed within the lumen of the delivery sheath with the outer frame in the second configuration. A first actuation wire is releasably coupled to a first portion of an open free end portion of the outer frame and a second actuation wire is releasably coupled to a second portion of the open free end portion of the outer frame. Each of the first actuation wire and the second actuation wire have a first portion extending proximally from the outer frame and a second portion extending proximally from the outer frame. The first portion and the second portion of each of the first actuation wire and the second actuation wire are configured to be pulled proximally to urge the outer frame from the second configuration towards the first configuration relative to the inner frame.
In some embodiments, an apparatus includes an outer sheath that defines a lumen, an inner sheath movably disposed within the lumen of the outer sheath and defining a lumen, a tube member movably disposed within the lumen of the outer sheath and defining a lumen, a valve holder movably disposed within the lumen of the inner sheath and within a lumen defined by the tube member and a prosthetic heart valve disposed at least partially within the lumen of the outer sheath and at least partially within the lumen of the inner sheath. The prosthetic heart valve includes an outer frame coupled to an inner frame and the inner frame is removably coupled to a distal end portion of the valve holder. The outer frame is movable between a first configuration relative to the inner frame and a second configuration relative to the inner frame in which the outer frame is inverted relative to the inner frame. The prosthetic heart valve is disposed within the lumen of the outer sheath and the lumen of the inner sheath with the outer frame in the second configuration. A first actuation wire is releasably coupled to a first portion of an open free end portion of the outer frame and releasably coupled to the tube member at a first location on the tube member. A second actuation wire is releasably coupled to a second portion of the open free end portion of the outer frame and releasably coupled to the tube member at a second location on the tube member.
In some embodiments, a method includes inserting a distal end portion of a delivery sheath into a left atrium of a heart. The delivery sheath having a prosthetic mitral valve disposed within a lumen of the delivery sheath and the prosthetic mitral valve has an outer frame coupled to an inner frame such that the outer frame can be moved between a first position relative to the inner frame and a second position relative to the inner frame in which the outer frame is inverted relative to the inner frame. The prosthetic valve is disposed within the lumen of the delivery sheath with the outer frame in the second positon relative to the inner frame. The prosthetic mitral valve is moved distally out of the delivery sheath causing the outer frame of the prosthetic mitral valve to revert back to the first position relative to the inner frame such that the prosthetic mitral valve at least partially assumes a biased expanded configuration. The prosthetic mitral valve is positioned within a mitral annulus of the heart.
The prosthetic heart valve 100 (also referred to herein as “prosthetic valve” or “valve”) can be, for example, a prosthetic mitral valve. The valve 100 includes an outer frame 120 and an inner frame 150. The outer frame 120 and the inner frame 150 are each formed as a tubular structure as described in more detail below with reference to
The outer frame 120 is configured to have a biased expanded or undeformed shape and can be manipulated and/or deformed (e.g., compressed or constrained) and, when released, return to its original (expanded or undeformed) shape. For example, the outer frame 120 can be formed of materials, such as metals or plastics, which have shape memory properties. With regards to metals, Nitinol® has been found to be especially useful since it can be processed to be austenitic, martensitic or super elastic. Other shape memory alloys, such as Cu—Zn—Al—Ni alloys, and Cu—Al—Ni alloys, may also be used. The inner frame 150 can be formed from a laser-cut tube of Nitinol®. The inner frame 150 can also have a biased expanded or undeformed shape and can be manipulated and/or deformed (e.g., compressed and/or constrained) and, when released, return to its original (expanded or undeformed) shape. Further details regarding the inner frame 150 and the outer frame 120 are described below with respect to valve 200 and
The valve 100 can be delivered and deployed within a left atrium of a heart using a variety of different delivery approaches including, for example, a transfemoral delivery approach, as described in the '572 PCT application and/or in the '305 PCT application, or a transatrial or transjugular approach, as described in the '704 provisional application, the '678 provisional application and the '790 publication”) incorporated by reference above. As described above, in some situations, such as when delivering a prosthetic valve to the heart via a transfemoral or transatrial approach, because of the smaller size of the lumen of the delivery sheath, the size of the prosthetic valve during delivery should be sized accordingly. Thus, it is desirable to have a prosthetic valve that can be reconfigured between a biased expanded configuration for implantation in the heart (e.g., within a native mitral annulus) and a delivery configuration that has a smaller outer perimeter or profile to allow for delivery within the lumen of the delivery sheath. The prosthetic valve 100 and the embodiments of a prosthetic valve described herein can be constructed and formed to achieve these desired functions and characteristics.
More specifically, the valve 100 can have a biased expanded configuration (as shown in
To enable the valve 100 to be moved to the inverted configuration, the outer frame 120 can be coupled to the inner frame 150 in such a manner to allow the outer frame 120 to move relative to the inner frame 150. More specifically, the coupling joints 146 can couple the outer frame 120 to the inner frame 150 in such a manner to allow the outer frame 120 to be moved relative to the inner frame 150. For example, in some embodiments, the coupling joints 146 can be configured to allow the outer frame 120 to rotate about the coupling joint 146 relative to the inner frame 150. In some embodiments, coupling joints can provide a pivotal coupling between the outer frame 120 and the inner frame 150. In some embodiments, the coupling joints can provide a flexible attachment between the outer frame 120 and the inner frame 150. The coupling joints 146 can be a variety of different types and configurations as described herein with reference to the various embodiments of a prosthetic valve. For example, the coupling joints 146 can include a living hinge, a flexible member, sutures, a suture wrapped through an opening, a pin or tab inserted through an opening or any combinations thereof.
To move the valve 100 from the expanded configuration (
When in the inverted configuration, an overall length of the valve 100 is increased, but a length of the inner frame 150 and a length of the outer frame 120 remains the same (or substantially the same). For example, as shown in
With the valve 100 in the inverted configuration, the valve 100 can be placed within a lumen of the delivery sheath 126 for delivery of the valve 100 to the left atrium of the heart, as shown in
Thus, by disposing the outer frame 120 in the inverted configuration, the valve 100 can be collapsed into a smaller overall diameter, i.e. placed in a smaller diameter delivery sheath 126, than would be possible if the valve 100 were merely collapsed radially. This is because when the valve is in the biased expanded configuration, the inner frame 150 is nested within an interior of the outer frame 120, and thus the outer frame 120 must be collapsed around the inner frame 150. In some embodiments, the inner frame 150 and the outer frame are disposed concentrically. Whereas in the inverted configuration, the inner frame 150 and the outer frame 120 are arranged axially with respect to each other (i.e., the inner frame is not nested within the outer frame 150), such that the outer frame 120 can be collapsed without needing to accommodate all of the structure of the inner frame 150 inside it. In other words, with the inner frame 150 disposed mostly inside or nested within the outer frame 120, the layers or bulk of the frame structures cannot be compressed to as small a diameter. In addition, if the frames are nested, the structure is less flexible, and therefore, more force is needed to bend the valve, e.g. to pass through tortuous vasculature or to make tight turn in the left atrium after passing through the atrial septum to be properly oriented for insertion into the mitral valve annulus.
As shown, outer frame assembly 210 includes an outer frame 220, covered on all or a portion of its outer face with an outer covering 230, and covered on all or a portion of its inner face by an inner covering 232. Outer frame 220 can provide several functions for prosthetic heart valve 200, including serving as the primary structure, as an anchoring mechanism and/or an attachment point for a separate anchoring mechanism to anchor the valve to the native heart valve apparatus, a support to carry inner valve assembly 240, and/or a seal to inhibit paravalvular leakage between prosthetic heart valve 200 and the native heart valve apparatus.
Outer frame 220 has a biased expanded configuration and can be manipulated and/or deformed (e.g., compressed and/or constrained) and, when released, return to its original unconstrained shape. To achieve this, outer frame 220 can be formed of materials, such as metals or plastics, which have shape memory properties. With regards to metals, Nitinol® has been found to be especially useful since it can be processed to be austenitic, martensitic or super elastic. Other shape memory alloys, such as Cu—Zn—Al—Ni alloys, and Cu—Al—Ni alloys, may also be used.
As best shown in
Inner valve assembly 240 includes an inner frame 250, an outer covering (not shown), and leaflets 270. As shown, the inner valve assembly 240 includes an upper portion having a periphery formed with multiple arches. The inner frame 250 includes six axial posts or frame members that support the outer covering of the inner valve assembly 240 and leaflets 270. Leaflets 270 are attached along three of the posts, shown as commissure posts 252 (best illustrated in
Although inner valve assembly 240 is shown as having three leaflets, in other embodiments, an inner valve assembly can include any suitable number of leaflets. The leaflets 270 are movable between an open configuration and a closed configuration in which the leaflets 270 coapt, or meet in a sealing abutment.
Outer covering 230 of the outer frame assembly 210 and inner covering 232 of outer frame assembly 210, outer covering 260 of the inner valve assembly 240 and leaflets 270 of the inner valve assembly 240 may be formed of any suitable material, or combination of materials, such as those discussed above. In this embodiment, the inner covering 232 of the outer frame assembly 210, the outer covering of the inner valve assembly 240, and the leaflets 270 of the inner valve assembly 240 are formed, at least in part, of porcine pericardium. Moreover, in this embodiment, the outer covering 230 of the outer frame assembly 210 is formed, at least in part, of polyester.
Inner frame 250 is shown in more detail in
In this embodiment, inner frame 250 is formed from a laser-cut tube of Nitinol®. Inner frame 250 is illustrated in
Tether connecting portion 244 (also referred to as first end portion of inner frame) includes longitudinal extensions of the struts, connected circumferentially by pairs of opposed, slightly V-shaped connecting members (or “micro-Vs”). Tether connecting portion 244 is configured to be radially collapsed by application of a compressive force, which causes the micro-Vs to become more deeply V-shaped, with the vertices moving closer together longitudinally and the open ends of the V shapes moving closer together circumferentially. Thus, tether connecting portion 244 can be configured to compressively clamp or grip one end of a tether, either connecting directly onto a tether line (e.g. braided filament line) or onto an intermediate structure, such as a polymer or metal piece that is in term firmly fixed to the tether line.
In contrast to tether connecting portion 244, atrial portion 247 (also referred to as “inner frame free end portion”) and body portion 242 are configured to be expanded radially. Strut portion 243 forms a longitudinal connection and radial transition between the expanded body portion and the compressed tether connecting portion 244. Body portion 242 provides an inner frame coupling portion 245 that includes six longitudinal posts, such as post 242A. The inner frame coupling portion 245 can be used to attach leaflets 270 to inner frame 240, and/or can be used to attach inner assembly 240 to outer assembly 210, such as by connecting inner frame 250 to outer frame 220. In the illustrated embodiment, the posts include openings through which connecting members (such as suture filaments and/or wires) can be passed to couple the posts to other structures.
Inner frame 250 is shown in a fully deformed, i.e. the final, deployed configuration, in side view and bottom view in
Outer frame 220 of valve 200 is shown in more detail in
Outer frame 220 is shown in a fully deformed, i.e. the final, deployed configuration, in side view and top view in
Outer frame 220 and inner frame 250 are shown coupled together in
As shown in
As the valve 300 exits the lumen of the delivery sheath 326, the outer frame assembly 310 exits first in its inverted configuration as shown in the progression of
The delivery sheath 426 can be used to deliver a valve 400 that includes an inner valve assembly 440 including an inner frame (not labeled in
As shown in
In alternative embodiments, the valve holder 438 can be removably coupled to the valve 400 (e.g., the inner frame 450 of the valve 400) via wires or sutures that can be cut after delivery of the valve 400 to the heart. In some cases, the valve holder 438 can be decoupled from the valve 400 when the valve is still disposed within the delivery sheath 426, while in other instances the valve holder 438 can be decoupled from the valve 400 after the valve 400 exits the delivery sheath 426 within the heart.
The actuation wires 474 and 476 can be coupled to the outer frame of the outer frame assembly 410 with a variety of different coupling methods. For example, the outer frame 410 can include loops (as described herein with respect to outer frame 510, outer frame 1010, and in the '305 PCT Application) through which the actuation wires 474 and 476 can be received or threaded. The number of loops on the outer frame can vary and the number of loops through which each actuation wire is connected can vary. For example, in some embodiments, the outer frame includes 12 loops and a first actuation wire is threaded through 6 of the loops and a second actuation wire is threaded through 6 of the loops. In other embodiments, the outer frame can include 12 loops and there can be 4 actuation wires, each coupled to 3 of the loops. In some embodiments, a single actuation wire is coupled through all of the loops of the outer frame.
In this embodiment, the delivery sheath 426 can be used to deliver the valve 400 to the left atrium of the heart using a transvascular approach (e.g., transfemoral, transatrial, transjugular). When the distal end of the delivery sheath 426 is disposed within the left atrium, the valve 400 is moved out of the lumen of the delivery sheath 426 using the actuation wires 474, 476 to assist in pulling the valve 400 out of the delivery sheath 426. In some cases, the valve holder 438 can also be used to push the valve 400 out of the delivery sheath 426. More specifically, the actuation wires 474 and 476 can extend from the outer frame assembly 410 out a distal end of the delivery sheath and extend proximally. In some embodiments, the actuation wires 474, 476 extend proximally outside the delivery sheath 426, then pass back into the lumen of the delivery sheath 426 through side apertures or holes (not shown) and then out a proximal end of the delivery sheath 426. Thus, a user (e.g., physician) can pull the proximal end portions of the actuation wires 474 and 476 to in turn pull the outer frame assembly 410 out of the distal end of the delivery sheath 426. In some embodiments, the actuation wires 474, 476 extend proximally from the outer frame assembly 410, back through the distal end of the delivery sheath 426 (e.g., rather than through side apertures or holes of the delivery sheath) and within the lumen of the delivery sheath, and then out a proximal end of the delivery sheath 426. Various different embodiments and configurations are described in more detail below.
As the outer frame assembly 410 exits the delivery sheath 426 it will still be in an inverted configuration relative to the inner valve assembly 440. After the outer frame assembly 410 is at least partially outside of the lumen of the delivery sheath 426, the outer frame assembly 410 can begin to revert to its expanded or deployed configuration (not shown in
As with other embodiments described herein and embodiments of the '305 PCT Application, the valve 500 can be moved from a biased expanded configuration to an inverted configuration for delivery of the valve 500 to the heart. More specifically, to place the valve 500 in the inverted configuration, the outer frame 520 can be moved to an inverted configuration relative to the inner frame 550. In this embodiment, the valve 500 is placed at least partially within the lumen of the inner sheath 508 when the valve 500 is in the inverted configuration, and disposed near a distal end of the inner sheath 508. The valve holder 538 is also disposed within the lumen 583 of the inner sheath 508. The inner frame 550 can be releasably coupled to the valve holder 538 with couplers 506 in the same or similar manner as described above with respect to couplers 406, couplers 1006, and/or any of the couplers described in the '305 PCT Application. Similarly, the outer frame 520 includes loops 562 through which actuation wires 574-577 can be threaded through in the same or similar manner as described herein (e.g., with respect to valve 1000) and/or in the '305 PCT Application. The inner sheath 508 is movably disposed within the outer delivery sheath 526. As shown in
In this embodiment, the inner sheath 508 defines side apertures 509 through which the actuation wires 574-577 can pass through. More specifically, as shown in
The actuation wires 574-577 can be pinned to the tube member 503 by the pinning members 578-1, 578-2, 578-3, 578-4 in the same or similar manner as described below with respect to the delivery system 1005. Thus, some details regarding, for example, the tube member 503, the pinning member 578-1, 578-2, 578-3, 578-4 and the actuation wires 574-577, and procedures performed therewith, are not described with respect to this embodiment. It should be understood that for features and functions not specifically discussed with respect to this embodiment, those features and functions can be the same as or similar to the delivery systems described in herein (e.g., the delivery system 1005) and/or in the '305 PCT Application.
A user (e.g., physician) can use the tube member 503, to which the actuation wires 574-577 are coupled, to control and/or manipulate movement and/or deployment of the valve 500 as described, for example, with respect to the delivery system 1005. In this embodiment, as shown, at least a portion of the actuation wires 574-577 can be disposed within the interior of the delivery sheath 526, thus limiting the exposure of the actuation wires 574-577 to areas external to the delivery sheath 526 for at least a portion of the delivery and/or deployment of the valve 500. Although the side apertures 509 defined by the inner sheath 508 are shown as disposed at or near the distal end portion of the inner sheath 508, in other embodiments, side apertures 509 can be disposed at any suitable location along the length of the inner sheath 508 (e.g., towards a middle portion or a proximal portion of the management sheath).
In this embodiment, to deliver the valve 500 to the heart, the distal end of the outer delivery sheath 526, with the valve 500, inner sheath 508, valve holder 538, and tube member 503 disposed therein, is disposed within the left atrium of the heart. With the distal end portion of the delivery sheath 526 disposed within the left atrium of the heart, the valve 500 can be deployed outside of the delivery sheath 526. For example, the inner sheath 508, valve holder 538, and tube member 503 can be moved distally relative to the outer sheath 526, moving or pushing the valve 500 outside the lumen 582 of the outer sheath 526. In addition, or alternatively, the outer sheath 526 can be moved or pulled proximally, leaving at least a portion of the valve 500 disposed within the heart. In some instances, the tether 536 coupled to the valve 500 can be used to help pull the valve 500 out of the lumen 582 of the outer sheath 526.
As described in other embodiments herein and embodiments of the '305 PCT Application, as the outer frame 520 becomes unconstrained by the outer sheath 526, the outer frame 520 can begin to revert to its expanded or uninverted configuration. The actuation wires 575-577 can be used to control the reversion of the outer frame 520. More specifically, after the outer frame 520 is disposed at least partially outside the distal end of the outer sheath 526, the tube member 503 can be pulled proximally such that the actuation wires (pinned to the tube member 503) pull the distally disposed portion of the outer frame 520 proximally (the same as or similar to as shown in
In addition, in some instances, the actuation wires 574-577 can assist in the articulation and placement of the valve 500 into its destination (e.g., a native annulus of an atrioventricular valve of a heart). For example, the actuation wires 574-577 can also be used to constrain, collapse, or otherwise move the valve 500 (e.g., radially compress the outer frame 520 of the valve 500) after the valve 500 exits the outer sheath 526 and is in its reverted, expanded or partially expanded configuration. More specifically, in this embodiment, the tube member 503 with the actuation wires 574-577 pinned thereto, can be manipulated by a user to move or urge the outer frame 520 to a more compressed configuration (similar to or the same as shown in
With the outer frame 520 of the valve 500 disposed in its non-inverted and at least partially expanded configuration, and in a desired positon within the heart, the inner frame 550 can be deployed. As described in the '305 PCT Application with respect to valve 2100, to decouple the inner frame 550 from the valve holder 538, the valve holder 538 can be moved distally and/or the inner sheath 508 can be moved proximally such that the valve holder 538 is disposed outside of the lumen 583 of the inner sheath 508. As such, the couplers 506 can be released from the recesses 504, releasing or decoupling the inner frame 550 from the valve holder 538. In some embodiments, the tether 536 can be pulled to help move the inner frame 550 outside of the inner sheath 508. When the inner frame 550 is released from the valve holder 538 and disposed outside the inner sheath 508, the inner frame 550 can assume its biased expanded configuration.
The actuation wires 574-577 can also be released or decoupled from the outer frame 520 before or after the inner frame 550 is released form the valve holder 538. To decouple the actuation wires 574-577 from the outer frame 520, one end of each of the actuation wires 574-577 can be unpinned or decoupled from the tube member 503. For example, the pinning member 578-3 can be withdrawn proximally from a groove of the tube member 503 (the same as or similar to the groove 1084 shown in and described with respect to the delivery system 1005) such that the second end of the actuation wire 577 and the second end of the actuation wire 575 are each released or unpinned from the tube member 503, but remain pinned by pinning members 578-2 and 578-1, respectively. Similarly, the pinning member 578-4 can be withdrawn proximally from the groove such that the second end of the actuation wire 574 and the second end of actuation wire 576 can each be released or unpinned from the tube member 503, but remain pinned by pinning members 578-2 and 578-1, respectively. With one end of each of the actuation wires 575-577 coupled to the tube member 503 (via pinning members 578-1 and 578-2 in this example), the tube member 503 can be pulled proximally, which in turn will pull the opposite ends of the actuation wires 574-577 out of the loops 562 of outer frame 520. Thus with the actuation wires 574-577 detached from the outer frame 520, the outer frame can assume a biased expanded or partially expanded configuration.
Although in the above example, the pinning members 578-3 and 578-4 are described as being withdrawn to release the ends of the actuation wires 574-577, alternatively, the pinning members 578-1 and 578-2 can be withdrawn leaving the actuation wires 574-577 pinned by pinning members 578-3 and 578-4. Further, the actuation wires 574-577 can be decoupled from the outer frame 520 at any suitable sequence or time period within the procedure. For example, in some instances it may be desirable for the actuation wires 574-577 to be released after the valve 500 has at least partially exited the delivery sheath 526 but before the valve 500 is seated within the native annulus of the atrioventricular valve. In other instances, for example, the actuation wires 574-577 can be released after the valve 500 has at least partially exited the outer delivery sheath 526 and after the valve 500 is seated within the native annulus of the atrioventricular valve.
In some instances, for example as shown in
In some embodiments, a prosthetic heart valve (e.g., any prosthetic heart valve described herein and/or in the '305 PCT Application) can include an outer frame having multiple rows of loops through which any suitable number of actuator wires can be routed and/or slidably disposed (e.g., to control the reversion profile and timing of the outer frame as it is deployed and delivered from a delivery sheath).
As with other embodiments described herein and embodiments of the '305 PCT Application, the valve 600 can be moved from a biased expanded configuration to an inverted configuration for delivery of the valve 600 to the heart, as shown in
In this embodiment, the actuation wires 674-679 extend proximally from the outer frame 620, within the lumen 682 of the outer delivery sheath 626, and out the proximal end of the outer delivery sheath 626. In alternative embodiments, the actuator wires 674-679 can be pinned to a tube member by pinning members (not shown in
In this embodiment, to deliver the valve 600 to the heart, the distal end of the outer delivery sheath 626, with the valve 600 disposed therein, is disposed within the left atrium of the heart. With the distal end portion of the outer delivery sheath 626 disposed within the left atrium of the heart, the valve 600 can be deployed outside of the outer sheath 626. For example, the valve 600 can be moved distally relative to the outer sheath 626 outside the lumen 682 of the outer sheath 626. In addition, or alternatively, the outer sheath 626 can be moved or pulled proximally, leaving at least a portion of the valve 600 disposed within the heart. In some embodiments, a tether (not shown) coupled to the valve 600 can be used to help pull the valve 600 out of the lumen 682 of the outer sheath 626.
As described in previous embodiments and embodiments of the '305 PCT Application, as the outer frame 620 becomes unconstrained by the outer sheath 626, the outer frame 620 can begin to revert to its expanded or uninverted configuration. The actuation wires 674-679 can be used to control the reversion of the outer frame 620. More specifically, after the outer frame 620 is disposed at least partially outside the distal end of the outer sheath 626, the proximal ends of the actuator wires 674-679 can be pulled proximally, which will in turn pull the open end of the outer frame 620 (to which the actuation wires 674-679 are coupled) distally to help revert the outer frame 620. For example, as described with respect to other embodiments herein and in the '305 PCT Application, a user (e.g., a physician) can pull the end portions of the actuator wires 674-679 to in turn move the outer frame 620 to its reverted configuration, as shown in
In this embodiment, the outer frame 620 has two rows of loops, each row having 12 loops. In alternative embodiments, however, an outer frame can have any suitable number of loops and/or rows of loops such that the outer frame 620 can be reverted in a controlled manner. For example, in some alternative embodiments, an outer frame can have 3 or more rows of loops. Further, in some embodiments, the loops can be integrally or monolithically formed with the outer frame, while in other embodiments, one or more of the loops can be formed separately from and coupled to the outer frame (e.g., sewn onto the outer frame).
In addition, in some instances, the actuation wires 674-679 can assist in the articulation and placement of the valve 600 into its destination (e.g., a native annulus of an atrioventricular valve of a heart). For example, the actuation wires 674-679 can also be used to constrain, collapse, or otherwise move the valve 600 (e.g., radially compress the outer frame 620 of the valve 600) after the valve 600 exits the outer sheath 626 and is in its reverted, expanded or partially expanded configuration.
With the outer frame 620 of the valve 600 disposed in its non-inverted and at least partially expanded configuration (see e.g.,
In some instances, the actuation wires 674-679 can be decoupled from the outer frame 620 at any suitable sequence or time period within the procedure. For example, in some instances it may be desirable for the actuation wires 674-677 to be released after the valve 600 has at least partially exited the delivery sheath 626 but before the valve 600 is seated within the native annulus of the atrioventricular valve. In other instances, for example, the actuation wires 674-679 can be released after the valve 600 has at least partially exited the outer delivery sheath 626 and after the valve 600 is seated within the native annulus of the atrioventricular valve.
The embodiments described above and in the '305 PCT Application are described for use in transfemoral delivery. In other embodiments, similar delivery devices and methods can be used for transapical delivery of a prosthetic heart valve. The following apparatus and methods are described herein for use in transapical delivery and deployment of prosthetic heart valves, such as prosthetic mitral valves, that can be configured to be moved to an inverted configuration for delivery of the prosthetic valve to within a heart of a patient. As described herein, in some embodiments, a prosthetic valve includes an outer frame that can be inverted relative to an inner frame when the prosthetic valve is in a biased expanded configuration. The prosthetic mitral valve can be formed with, for example, a shape-memory material. After inverting the outer frame, the prosthetic valve can be inserted into a lumen of a delivery sheath such that the prosthetic valve is moved to a collapsed configuration.
The delivery sheath can be used to deliver the prosthetic valve to within a patient's heart using a variety of different delivery approaches for delivering a prosthetic heart valve (e.g., a prosthetic mitral valve) where the inverted prosthetic valve would enter the heart through the ventricle of the heart and into the atrium of the heart. For example, as described in further detail herein with respect to
After the delivery sheath has been disposed within the left atrium of the heart (e.g., via an apical approach), the prosthetic mitral valve is moved distally out of the delivery sheath such that the inverted outer frame reverts and the prosthetic valve assumes its biased expanded configuration. The prosthetic mitral valve can then be positioned within a mitral annulus of the heart.
The outer frame 720 is configured to have a biased expanded or undeformed shape and can be manipulated and/or deformed (e.g., compressed or constrained) and, when released, return to its original (expanded or undeformed) shape. For example, the outer frame 720 can be formed of materials, such as metals or plastics, that have shape memory properties. With regards to metals, Nitinol® has been found to be especially useful since it can be processed to be austenitic, martensitic or super elastic. Other shape memory alloys, such as Cu—Zn—Al—Ni alloys, and Cu—Al—Ni alloys, may also be used. The inner frame 750 can be formed from a laser-cut tube of Nitinol®. The inner frame 750 can also have a biased expanded or undeformed shape and can be manipulated and/or deformed (e.g., compressed and/or constrained) and, when released, return to its original (expanded or undeformed) shape.
The valve 700 can be delivered and deployed within a left atrium of a heart using a variety of different delivery approaches including, for example, a transapical delivery approach, as described in more detail below, or, for example, a transatrial, transjugular or transfemoral approach. As described above, in some situations, such as when delivering a prosthetic valve to the heart via a transapical approach, it may be desirable to use a delivery sheath with a relatively small lumen, and therefore, the size of the prosthetic valve during delivery should be sized accordingly. Thus, it is desirable to have a prosthetic valve that can be reconfigured between a biased expanded configuration for implantation in the heart (e.g., within a native mitral annulus) and a delivery configuration that has a smaller outer perimeter or profile to allow for delivery within the lumen of the delivery sheath. The prosthetic valve 700 and the embodiments of a prosthetic valve described herein can be constructed and formed to achieve these desired functions and characteristics.
More specifically, the valve 700 can have a biased expanded configuration (as shown in
To enable the valve 700 to be moved to the inverted configuration, the outer frame 720 can be coupled to the inner frame 750 in such a manner to allow the outer frame 720 to move relative to the inner frame 750. More specifically, the coupling joints 746 can couple the outer frame 720 to the inner frame 750 in such a manner to allow the outer frame 720 to be moved relative to the inner frame 750. For example, in some embodiments, the coupling joints 746 can be configured to allow the outer frame 720 to rotate about the coupling joint 746 relative to the inner frame 750. In some embodiments, coupling joints can provide a pivotal coupling between the outer frame 720 and the inner frame 750. In some embodiments, the coupling joints can provide a flexible attachment between the outer frame 720 and the inner frame 750. The coupling joints 746 can be a variety of different types and configurations as described in the '305 application incorporated herein with reference to the various embodiments of a prosthetic valve. For example, the coupling joints 746 can include a living hinge, a flexible member, sutures, a suture wrapped through an opening, a pin or tab inserted through an opening or any combinations thereof.
To move the valve 700 from the expanded configuration (
When in the inverted configuration, an overall length of the valve 700 is increased, but a length of the inner frame 750 and a length of the outer frame 720 remains the same (or substantially the same). For example, as shown in
With the valve 700 in the inverted configuration, the valve 700 can be placed within a lumen of the delivery sheath 726 for delivery of the valve 700 to the left ventricle and left atrium of the heart, as shown in
Thus, by disposing the outer frame 720 in the inverted configuration, the valve 700 can be collapsed into a smaller overall diameter, i.e. placed in a smaller diameter delivery sheath 726, than would be possible if the valve 700 were merely collapsed radially. This is because when the valve is in the biased expanded configuration, the inner frame 750 is nested within an interior of the outer frame 720, and thus the outer frame 720 must be collapsed around the inner frame 750. In some embodiments, the inner frame 750 and the outer frame are disposed concentrically. Whereas in the inverted configuration, the inner frame 750 and the outer frame 720 are arranged axially with respect to each other (i.e., the inner frame is not nested within the outer frame 750), such that the outer frame 720 can be collapsed without needing to accommodate all of the structure of the inner frame 750 inside it. In other words, with the inner frame 750 disposed mostly inside or nested within the outer frame 720, the layers or bulk of the frame structures cannot be compressed to as small a diameter. In addition, if the frames are nested, the structure is less flexible, and therefore, more force is needed to bend the valve, e.g. to pass through tortuous anatomy or to make turns through a patient to be properly oriented for insertion into the mitral valve annulus.
The delivery sheath 826 can be used to deliver a valve 800 that includes an inner valve assembly 840 including an inner frame (not labeled in
The dilator 870 has a fluid delivery portion 872 and a collapsible dilation portion 873 (also referred to herein as “dilation portion”). The fluid delivery portion 872 is configured to receive a fluid and deliver the fluid to the dilation portion 873 to inflate the dilation portion 873. The dilation portion 873 is configured to be inflated such that when inflated it can dilate (e.g., expand an opening or passage) to one or more portions of the heart as the delivery system 805 is introduced into the heart of the patient. For example, in use during a transapical delivery approach, the dilation portion 873, when inflated, can extend outside a distal end of the delivery sheath 826 and provide a lead-in for the delivery sheath 826 and help open or enlarge the entry opening at the epicardial surface and ease entry through the mitral annulus without entangling the valve's chordae tendinae. With the delivery sheath 826 placed at a desired position within the heart, the dilator portion 873 can be deflated and removed leaving the delivery sheath 826 within the heart.
The dilation portion 873 can have any suitable shape or size to dilate a portion of the heart (e.g., an incision in an apical portion of the heart) and thereby assist delivery of the valve 800 to the atrium of the heart. For example, in some embodiments, a dilation portion can have a conical and/or tapered shape with a rounded or blunt distal tip. In other embodiments, a dilation portion can have a round shape, an oval shape, triangular, or other suitable shape. Although not shown, in some embodiments, a dilator can define a guide wire lumen therethrough. During delivery of a prosthetic valve, for example, a guidewire can be extended through an apical portion of the heart, through the left ventricle and into the left atrium of the heart. In such an embodiment, the dilator can be threaded over the guidewire to be inserted into the heart. The guidewire can be any suitable size. For example, in some embodiments, the guidewire can be from about a 0.03″ guidewire to a 0.04″ guidewire (e.g., a 0.035″ guidewire). An example dilator device is described in U.S. patent application No. 14,527,382, filed Oct. 29, 2014 (“the '382 application”), the entire disclosure of which is incorporated herein by reference. As described in more detail herein, with the delivery sheath 826 placed at the desired position within the heart, the dilator portion 873 can be deflated (by removing the fluid therefrom) and removed along the guidewire leaving the delivery sheath 826 within the heart.
The elongate member 880 can be used to flip the outer frame assembly 810 and deliver to and retract from the heart at least a portion of the dilator 870. The elongate member 880 defines a dilator lumen 882 configured to slidably receive the dilator 870. More specifically, the dilator lumen 882 is configured to slidably receive the delivery portion 872, and the dilation portion 873 when deflated, as described in more detail herein. The elongate member 880 further defines four actuator wire lumens 884 (as shown in
The actuation wires 874, 876 can be coupled to the outer frame of the outer frame assembly 810 with a variety of different coupling methods. For example, the outer frame of the outer frame assembly 810 can include loops (not shown in
To deliver and deploy the prosthetic valve 800 within a heart, the delivery sheath 826 can be inserted through the epicardial surface of the patient's heart (e.g., at or near an apex region of the heart) and extended through the left ventricle and to the left atrium of the heart. Prior to inserting the delivery sheath 826 into the heart, with the dilation portion 873 of the dilator 870 extending outside a distal end of the delivery sheath 826, a fluid can be injected to the fluid delivery portion 872 thereby inflating the dilation portion 873 of the dilator 870. The distal end portion (e.g., tapered distal end) of the dilation portion 873 can provide a lead-in for the delivery sheath 826 and help open or enlarge the entry opening at the epicardial surface and through the mitral annulus. When the delivery sheath 826 is placed at the desired position within the heart, the fluid can be at least partially withdrawn or removed from the dilation portion 873 thereby deflating the dilation portion 873, and the deflated dilation portion 873 can be removed through the delivery catheter 826, leaving the delivery sheath 826, the inner valve assembly 840 and the outer frame assembly 810 within the heart.
With the distal end of the delivery sheath 826 disposed within the left atrium, the valve 800 can be moved out of the lumen of the delivery sheath 826 by withdrawing the delivery sheath 826 proximally and/or using a pusher device to push the valve 800 out the distal end of the delivery sheath 826 and/or using the elongate member 880 and actuation wires 874, 876 to assist in pulling the valve 800 out of the distal end of the delivery sheath 826. More specifically, with the actuation wires 874, 876 coupled to the outer frame assembly 810, the ends of the actuation wires 874, 876 can extend distally from the outer frame assembly 810 out the distal end of the delivery sheath 826 and then pass into the actuation wire lumens 884 of the elongate member 880 via side apertures or holes 886 (labeled in
In some embodiments, the end portions of the actuation wires 874, 876 extend proximally from the proximal end of the elongate member 880 and are operably coupled to a handle (not shown). The handle can be manipulated by a user to selectively pull and/or release the actuation wires 874, 876. In some embodiments, the handle can include one or more toggle switches or similar mechanisms to help control the transition of the valve 800. In this manner, a user can use the handle to selectively pull the valve 800 distally and out from the delivery sheath 826, and selectively control the flipping or transition between configurations of the outer frame assembly 810. In some embodiments, the end portions of actuation wires extend proximally through actuation wire lumens of a delivery sheath and out the proximal end of an elongate member, but remain within the delivery sheath. In such embodiments, a handle or functionally similar actuation wire manipulator is operably coupled to the actuation wires, and can be actuated and/or manipulated to selectively pull or release the actuation wires for delivery and/or deployment of the valve 800, as described above.
During delivery of the valve 800, as the inner valve assembly 840 exits the distal end of the delivery sheath 826, the outer frame assembly 810 will be in an inverted configuration relative to the inner valve assembly 840 (similar to as shown and described with respect to
With the outer frame assembly 810 reverted relative to the inner valve assembly 840 such that the valve 800 is disposed in its deployed configuration within the annulus of the heart, the delivery system 805 can be removed from the heart. For example, the actuation wires 874, 876 can be decoupled from the outer frame assembly 810 and removed from the heart via the elongate member 880, and the elongate member 880 and the delivery sheath 826 can be withdrawn from the heart, leaving the valve 800 implanted within the annulus of the heart. More specifically, to decouple the actuation wires 874, 876 from the outer frame assembly 810 and remove the actuation wires 874, 876 from the patient, a single proximal end of the actuation wires 874, 876 can be pulled proximally such that the other proximal end of the actuation wires 874, 876 gets pulled distally through the actuator wire lumens 884, out the apertures or holes 886 in the elongate member 880, through the loops of the outer frame 820, and back out through the actuator wire lumens 884. In this manner, the actuation wires 874, 876 can be removed from the elongate member 880, the delivery sheath 826, and the patient after the actuation wires 874, 876 are used to facilitate delivery and deployment of the valve 800 within the heart.
The delivery system 905 includes a delivery sheath 926, a dilator 970, an elongate member 980, and two actuation wires 974 and 976.
The elongate member 980 can be used to assist in the flipping of the outer frame assembly 910 and deliver to and retract from the heart at least a portion of the dilator. As shown in
In this embodiment, as shown, the actuation wires 974, 976 can be releasably coupled to the outer frame of the outer frame assembly 910. For example, as shown in
To deliver and deploy the prosthetic valve 900 within a heart, the delivery sheath 926 can be inserted through the epicardial surface of the patient's heart (e.g., at or near an apex region of the heart) and extended through the left ventricle and to the left atrium of the heart. Prior to inserting the delivery sheath 926 into the heart, with the dilation portion of the dilator extending outside a distal end of the delivery sheath 926, a fluid can be injected to the fluid delivery portion 972 thereby inflating the dilation portion 973 of the dilator 970. The distal end portion (e.g., tapered distal end) of the dilation portion 973 can provide a lead-in for the delivery sheath 926 and help open or enlarge the entry opening at the epicardial surface and through the mitral annulus. When the delivery sheath 926 is placed at the desired position within the heart, the fluid can be at least partially withdrawn or removed from the dilation portion 973 thereby deflating the dilation portion 973, and the deflated dilation portion 973 can be removed through the delivery catheter 926, leaving the delivery sheath 926, the inner valve assembly 940 and the outer frame assembly 910 within the heart.
With the distal end of the delivery sheath 926 disposed within the left atrium, the valve 900 can be moved out of the lumen of the delivery sheath 926 by, for example, withdrawing the delivery sheath 926 proximally and/or moving the elongate member 980 distally and using the actuation wires 974, 976 to assist in pulling the valve 900 out of the distal end of the delivery sheath 926. As described above for the previous embodiment, the inner valve assembly 940 will exit the delivery sheath 926 first and then the outer frame assembly 910. Unconstrained by the delivery sheath 926, the inner valve assembly 940 and outer frame assembly 910 can assume their biased expanded configurations.
To flip or revert the outer frame assembly 910, the elongate member 980 can be moved distally out of the delivery sheath 926 as shown in
As described above, as the valve 900 exits the distal end of the delivery sheath 926, the outer frame assembly 910 will be in an inverted configuration relative to the inner valve assembly 940 (similar to as shown and described with respect to
With the outer frame assembly 910 reverted relative to the inner valve assembly 940 such that the valve 900 is disposed in its deployed configuration (as shown in
In some embodiments, after the valve 900 has been delivered and deployed within the heart, the delivery sheath 926 can be moved distally (before and/or after the actuation wires 974, 976 have been removed from the elongate member 980, the delivery sheath 926, and/or the patient) to capture or otherwise engage with at least a proximal portion of the valve 900 and at least partially collapse the proximal portion of the valve. The delivery sheath 926 can then be used to move and/or reorient (e.g., rotate, clock, angle) the valve 900 within the heart. For example, a user can rotate the delivery sheath 926 about its longitudinal axis to in turn rotate the valve 900 about its longitudinal axis. In this manner, a user can ensure proper implantation of the valve 900 within the heart without having to remove the valve 900 from the heart, for example, when the valve 900 is not first implanted in a proper manner.
For example, to dispose the outer frame 1020 in its inverted configuration relative to the inner frame 1050, the outer frame 1020 is folded or inverted distally such that the outer frame 1020 is pointed away from the inner frame 1050. With the outer frame 1020 in the inverted configuration, the valve 1000 can be placed within a lumen of the delivery system 1005 as shown in
In this embodiment, the delivery system 1005 includes an outer delivery sheath 1026, an inner sheath 1008, a valve holder 1038 (also referred to as a “pusher”) and a multi-lumen elongate tube member 1003 (also referred to as “tube” or “tube member” or “multi-lumen elongate member”). As shown in
To deploy the valve 1000 within a heart, the outer frame 1020 of the valve 1000 is first moved or placed in its inverted configuration relative to the inner frame 1050. As shown in
The inner frame 1050 can be releasably coupled to the valve holder 1038 via couplers 1006 that are received within corresponding recesses 1004 defined by the valve holder 1038 in the same manner as described above for delivery system 405 (see, e.g.,
In alternative embodiments, the valve holder 1038 can be removably coupled to the valve 1000 (e.g., the inner frame 1050 of the valve 1000) via wires or sutures that can be cut after delivery of the valve 1000 to the heart. In some cases, the valve holder 1038 can be decoupled from the valve 1000 when the valve is still disposed within the outer delivery sheath 1026, while in other instances the valve holder 1038 can be decoupled from the valve 1000 after the valve 1000 exits the delivery sheath 1026 within the heart.
Although not shown, in other embodiments, the valve holder 1038 can merely contact and push the valve 1000 during deployment, as described for previous embodiments, without securing the inner frame 1050 to the valve holder 1038. In such embodiments, in some instances, radial expansion of the inner frame 1050 can be restricted by the inner sheath 1008 when the inner frame 1050 is disposed therein.
In this embodiment a first actuation wire 1076, a second actuation wire 1074, a third actuation wire 1076 and a fourth actuation wire 1077 are each coupled to the outer frame assembly 1010. More specifically, the outer frame 1020 of the outer frame assembly 1010 includes loops 1062 through which the actuation wires 1074-1077 can be threaded or received therethrough. In this embodiment, the outer frame 1020 includes 12 loops 1062 and each actuation wire 1074-1077 is threaded through 3 of the loops 1062. In other embodiments, there can be a different number of loops disposed on the outer frame 1020 and there can be a different number of actuators. Further, each actuation wire can be threaded or received through a different number of loops than shown for this embodiment.
When the valve 1000 is disposed within the delivery system 1005 as shown, for example, in
As shown in
As shown in
As shown in
As shown in
The distal retention element 1186 also defines pinning member lumens 1169 that align with the pinning member lumens 1179 of the multi-lumen tube member 1103 such that the pinning members 1078 can be received therein. A proximal shoulder 1188 can be disposed abutting a distal end of the multi-lumen tube member 1103. The distal retention element 1186 also defines a circumferential recess area 1184 defined between the proximal shoulder 1188 and a distal end portion of the distal retention element 1186. As shown in
The procedure to deliver the valve 1000 to the heart can be the same as or similar to any of the procedures described herein, in '572 PCT Application and/or the '305 PCT Application incorporated by reference above. For example, the valve 1000, disposed within the delivery system 1005 in an inverted configuration, can be delivered to the left atrium of the heart in the same or similar manner as described herein with respect to other embodiments and/or with reference to FIGS. 43-48 of the '305 PCT Application. With the distal end portion of the delivery sheath 1026 disposed within the left atrium of the heart, the valve 1000 can be deployed outside of the delivery sheath 1026. For example, as shown in
As described above for previous embodiments, as the outer frame 1020 becomes unconstrained by the outer sheath 1026, the outer frame 1020 can begin to revert to its expanded or uninverted configuration. The actuation wires 1075-1077 can be used to control the reversion of the outer frame 1020. More specifically, the tube member 1003 can be pulled proximally such that the actuation wires (pinned to the tube member 1003) pull the distally disposed portion of the outer frame 1020 proximally (as shown in
In addition, in some instances, the actuation wires 1074-1077 can assist in the articulation and placement of the valve 1000 into its destination (e.g., a native annulus of an atrioventricular valve of a heart). For example, as shown in
Referring back to
The actuation wires 1074-1077 can also be released or decoupled from the outer frame 1020 before or after the inner frame 1050 is released form the valve holder 1038. To decouple the actuation wires 1074-1077 from the outer frame 1020, one end of each of the actuation wires 1074-1077 can be unpinned or decoupled from the tubular member 1003. For example, as shown in
Although in the above example, the pinning members 1078-3 and 1078-4 are shown withdrawn to release the ends of the actuation wires 1074-1077, alternatively, the pinning members 1078-1 and 1078-2 can be withdrawn leaving the actuation wires 1074-1077 pinned by pinning members 1078-3 and 1078-4. Further, the actuation wires 1074-1077 can be decoupled from the outer frame 1020 at any suitable sequence or time period within the procedure. For example, in some instances it may be desirable for the actuation wires 1074-1077 to be released after the valve 1000 has at least partially exited the delivery sheath 1026 but before the valve 1000 is seated within the native annulus of the atrioventricular valve. In other instances, for example, the actuation wires 1074-1077 can be released after the valve 1000 has at least partially exited the outer delivery sheath 1026 and after the valve 1000 is seated within the native annulus of the atrioventricular valve.
While various embodiments have been described above, it should be understood that they have been presented by way of example only, and not limitation. Where methods described above indicate certain events occurring in certain order, the ordering of certain events may be modified. Additionally, certain of the events may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above
Where schematics and/or embodiments described above indicate certain components arranged in certain orientations or positions, the arrangement of components may be modified. While the embodiments have been particularly shown and described, it will be understood that various changes in form and details may be made. Any portion of the apparatus and/or methods described herein may be combined in any combination, except mutually exclusive combinations. The embodiments described herein can include various combinations and/or sub-combinations of the functions, components, and/or features of the different embodiments described.
For example, although not specifically described for each embodiment, any of the embodiments of a delivery system can include a dilator device or member such as balloon dilator member. Further, the prosthetic heart valves described herein can be secured to a heart using an epicardial pad device as described with respect to FIGS. 43-48 and 72 of the '305 PCT Application. Moreover, although not shown for each embodiment, any of the embodiments of a delivery device or system can include a valve holder or valve pusher configured to urge the valve out the distal end of the delivery sheath during delivery of the valve.
Further, although not shown, any of the embodiments of a delivery device or system can include a handle or handle assembly to which the various delivery sheaths and components can be operatively coupled and which a user (e.g., physician) can grasp and use to manipulate the delivery device or system.
In addition, the systems and methods described herein can also be adapted for use with a prosthetic tricuspid valve. For example, in such a case, a procedural catheter can be inserted into the right ventricle of the heart, and the delivery sheath delivered to the right atrium of the heart either directly (transatrial), or via the jugular or femoral vein.
In addition, the systems and methods described herein can also be adapted for use with a prosthetic tricuspid valve. For example, in such a case, a delivery sheath can be delivered to the heart transapically.
This application is a continuation of U.S. patent application Ser. No. 16/310,661, filed Dec. 17, 2018, which is a national phase entry under 35 U.S.C. § 371 of International Application No. PCT/US2017/039972 filed Jun. 29, 2017, published in English, which claims priority to and the benefit of U.S. Provisional Application No. 62/356,828, filed Jun. 30, 2016, entitled “Prosthetic Heart Valves and Apparatus and Methods for Delivery of Same,” the disclosures of which are all incorporated herein by reference in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
2697008 | Ross | Dec 1954 | A |
3409013 | Berry | Nov 1968 | A |
3472230 | Fogarty et al. | Oct 1969 | A |
3476101 | Ross | Nov 1969 | A |
3548417 | Kischer | Dec 1970 | A |
3587115 | Shiley | Jun 1971 | A |
3657744 | Ersek | Apr 1972 | A |
3671979 | Moulopoulos | Jun 1972 | A |
3714671 | Edwards et al. | Feb 1973 | A |
3755823 | Hancock | Sep 1973 | A |
3976079 | Samuels et al. | Aug 1976 | A |
4003382 | Dyke | Jan 1977 | A |
4035849 | Angell et al. | Jul 1977 | A |
4056854 | Boretos et al. | Nov 1977 | A |
4073438 | Meyer | Feb 1978 | A |
4106129 | Carpentier et al. | Aug 1978 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4265694 | Boretos et al. | May 1981 | A |
4297749 | Davis et al. | Nov 1981 | A |
4339831 | Johnson | Jul 1982 | A |
4343048 | Ross et al. | Aug 1982 | A |
4345340 | Rosen | Aug 1982 | A |
4373216 | Klawitter | Feb 1983 | A |
4406022 | Roy | Sep 1983 | A |
4470157 | Love | Sep 1984 | A |
4490859 | Black et al. | Jan 1985 | A |
4535483 | Klawitter et al. | Aug 1985 | A |
4574803 | Storz | Mar 1986 | A |
4585705 | Broderick et al. | Apr 1986 | A |
4592340 | Boyles | Jun 1986 | A |
4605407 | Black et al. | Aug 1986 | A |
4612011 | Kautzky | Sep 1986 | A |
4626255 | Reichart et al. | Dec 1986 | A |
4638886 | Marietta | Jan 1987 | A |
4643732 | Pietsch et al. | Feb 1987 | A |
4655771 | Wallsten | Apr 1987 | A |
4692164 | Dzemeshkevich et al. | Sep 1987 | A |
4733665 | Palmaz | Mar 1988 | A |
4759758 | Gabbay | Jul 1988 | A |
4762128 | Rosenbluth | Aug 1988 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4787899 | Lazarus | Nov 1988 | A |
4787901 | Baykut | Nov 1988 | A |
4796629 | Grayzel | Jan 1989 | A |
4824180 | Levrai | Apr 1989 | A |
4829990 | Thuroff et al. | May 1989 | A |
4830117 | Capasso | May 1989 | A |
4851001 | Taheri | Jul 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
4878495 | Grayzel | Nov 1989 | A |
4878906 | Lindemann et al. | Nov 1989 | A |
4883458 | Shiber | Nov 1989 | A |
4922905 | Strecker | May 1990 | A |
4923013 | De Gennaro | May 1990 | A |
4960424 | Grooters | Oct 1990 | A |
4966604 | Reiss | Oct 1990 | A |
4979939 | Shiber | Dec 1990 | A |
4986830 | Owens et al. | Jan 1991 | A |
4994077 | Dobben | Feb 1991 | A |
4996873 | Takeuchi | Mar 1991 | A |
5007896 | Shiber | Apr 1991 | A |
5026366 | Leckrone | Jun 1991 | A |
5032128 | Alonso | Jul 1991 | A |
5035706 | Giantureo et al. | Jul 1991 | A |
5037434 | Lane | Aug 1991 | A |
5047041 | Samuels | Sep 1991 | A |
5059177 | Towne et al. | Oct 1991 | A |
5064435 | Porter | Nov 1991 | A |
5080668 | Bolz et al. | Jan 1992 | A |
5085635 | Cragg | Feb 1992 | A |
5089015 | Ross | Feb 1992 | A |
5152771 | Sabbaghian et al. | Oct 1992 | A |
5163953 | Vince | Nov 1992 | A |
5167628 | Boyles | Dec 1992 | A |
5192297 | Hull | Mar 1993 | A |
5201880 | Wright et al. | Apr 1993 | A |
5266073 | Wall | Nov 1993 | A |
5282847 | Trescony et al. | Feb 1994 | A |
5295958 | Shturman | Mar 1994 | A |
5306296 | Wright et al. | Apr 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5336616 | Livesey et al. | Aug 1994 | A |
5344442 | Deac | Sep 1994 | A |
5360444 | Kusuhara | Nov 1994 | A |
5364407 | Poll | Nov 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5397351 | Pavcnik et al. | Mar 1995 | A |
5411055 | Kane | May 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5415667 | Frater | May 1995 | A |
5443446 | Shturman | Aug 1995 | A |
5480424 | Cox | Jan 1996 | A |
5500014 | Quijano et al. | Mar 1996 | A |
5545209 | Roberts et al. | Aug 1996 | A |
5545214 | Stevens | Aug 1996 | A |
5549665 | Vesely et al. | Aug 1996 | A |
5554184 | Machiraju | Sep 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5571175 | Vanney et al. | Nov 1996 | A |
5591185 | Kilmer et al. | Jan 1997 | A |
5607462 | Imran | Mar 1997 | A |
5607464 | Frescony et al. | Mar 1997 | A |
5609626 | Quijano et al. | Mar 1997 | A |
5639274 | Fischell et al. | Jun 1997 | A |
5662704 | Gross | Sep 1997 | A |
5665115 | Cragg | Sep 1997 | A |
5674279 | Wright et al. | Oct 1997 | A |
5697905 | d'Ambrosio | Dec 1997 | A |
5702368 | Stevens et al. | Dec 1997 | A |
5716417 | Girard et al. | Feb 1998 | A |
5728068 | Leone et al. | Mar 1998 | A |
5728151 | Garrison et al. | Mar 1998 | A |
5735842 | Krueger et al. | Apr 1998 | A |
5741333 | Frid | Apr 1998 | A |
5749890 | Shaknovich | May 1998 | A |
5756476 | Epstein et al. | May 1998 | A |
5769812 | Stevens et al. | Jun 1998 | A |
5792179 | Sideris | Aug 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5833673 | Ockuly et al. | Nov 1998 | A |
5840081 | Andersen et al. | Nov 1998 | A |
5855597 | Jayaraman | Jan 1999 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5855602 | Angell | Jan 1999 | A |
5904697 | Gifford, III et al. | May 1999 | A |
5925063 | Khosravi | Jul 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
5968052 | Sullivan, III et al. | Oct 1999 | A |
5968068 | Dehdashtian et al. | Oct 1999 | A |
5972030 | Garrison et al. | Oct 1999 | A |
5993481 | Marcade et al. | Nov 1999 | A |
6027525 | Suh et al. | Feb 2000 | A |
6042607 | Williamson, IV et al. | Mar 2000 | A |
6045497 | Schweich, Jr. et al. | Apr 2000 | A |
6063112 | Sgro | May 2000 | A |
6077214 | Mortier et al. | Jun 2000 | A |
6099508 | Bousquet | Aug 2000 | A |
6132473 | Williams et al. | Oct 2000 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6171335 | Wheatley et al. | Jan 2001 | B1 |
6174327 | Mertens et al. | Jan 2001 | B1 |
6183411 | Mortier et al. | Feb 2001 | B1 |
6210408 | Chandrasekaran et al. | Apr 2001 | B1 |
6217585 | Houser et al. | Apr 2001 | B1 |
6221091 | Khosravi | Apr 2001 | B1 |
6231602 | Carpentier et al. | May 2001 | B1 |
6245102 | Jayaraman | Jun 2001 | B1 |
6260552 | Mortier et al. | Jul 2001 | B1 |
6261222 | Schweich, Jr. et al. | Jul 2001 | B1 |
6264602 | Mortier et al. | Jul 2001 | B1 |
6287339 | Vazquez et al. | Sep 2001 | B1 |
6299637 | Shaolian et al. | Oct 2001 | B1 |
6302906 | Goicoechea et al. | Oct 2001 | B1 |
6312465 | Griffin et al. | Nov 2001 | B1 |
6332893 | Mortier et al. | Dec 2001 | B1 |
6350277 | Kocur | Feb 2002 | B1 |
6358277 | Duran | Mar 2002 | B1 |
6379372 | Dehdashtian et al. | Apr 2002 | B1 |
6402679 | Mortier et al. | Jun 2002 | B1 |
6402680 | Mortier et al. | Jun 2002 | B2 |
6402781 | Langberg et al. | Jun 2002 | B1 |
6406420 | McCarthy et al. | Jun 2002 | B1 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6440164 | DiMatteo et al. | Aug 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6461382 | Cao | Oct 2002 | B1 |
6468660 | Ogle et al. | Oct 2002 | B2 |
6482228 | Norred | Nov 2002 | B1 |
6488704 | Connelly et al. | Dec 2002 | B1 |
6537198 | Vidlund et al. | Mar 2003 | B1 |
6540782 | Snyders | Apr 2003 | B1 |
6569196 | Vesely | May 2003 | B1 |
6575252 | Reed | Jun 2003 | B2 |
6582462 | Andersen et al. | Jun 2003 | B1 |
6605112 | Moll et al. | Aug 2003 | B1 |
6616684 | Vidlund et al. | Sep 2003 | B1 |
6622730 | Ekvall et al. | Sep 2003 | B2 |
6629534 | St. Goar et al. | Oct 2003 | B1 |
6629921 | Schweich, Jr. et al. | Oct 2003 | B1 |
6648077 | Hoffman | Nov 2003 | B2 |
6648921 | Anderson et al. | Nov 2003 | B2 |
6652578 | Bailey et al. | Nov 2003 | B2 |
6669724 | Park et al. | Dec 2003 | B2 |
6706065 | Langberg et al. | Mar 2004 | B2 |
6709456 | Langberg et al. | Mar 2004 | B2 |
6723038 | Schroeder et al. | Apr 2004 | B1 |
6726715 | Sutherland | Apr 2004 | B2 |
6730118 | Spenser et al. | May 2004 | B2 |
6733525 | Yang et al. | May 2004 | B2 |
6740105 | Yodfat et al. | May 2004 | B2 |
6746401 | Panescu | Jun 2004 | B2 |
6746471 | Mortier et al. | Jun 2004 | B2 |
6752813 | Goldfarb et al. | Jun 2004 | B2 |
6764510 | Vidlund et al. | Jul 2004 | B2 |
6797002 | Spence et al. | Sep 2004 | B2 |
6810882 | Langberg et al. | Nov 2004 | B2 |
6830584 | Seguin | Dec 2004 | B1 |
6854668 | Wancho et al. | Feb 2005 | B2 |
6855144 | Lesh | Feb 2005 | B2 |
6858001 | Aboul-Hosn | Feb 2005 | B1 |
6890353 | Cohn et al. | May 2005 | B2 |
6893460 | Spenser et al. | May 2005 | B2 |
6896690 | Lambrecht et al. | May 2005 | B1 |
6908424 | Mortier et al. | Jun 2005 | B2 |
6908481 | Cribier | Jun 2005 | B2 |
6936067 | Buchanan | Aug 2005 | B2 |
6945996 | Sedransk | Sep 2005 | B2 |
6955175 | Stevens et al. | Oct 2005 | B2 |
6974476 | McGuckin, Jr. et al. | Dec 2005 | B2 |
6976543 | Fischer | Dec 2005 | B1 |
6997950 | Chawla | Feb 2006 | B2 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7018408 | Bailey et al. | Mar 2006 | B2 |
7044905 | Vidlund et al. | May 2006 | B2 |
7060021 | Wilk | Jun 2006 | B1 |
7077862 | Vidlund et al. | Jul 2006 | B2 |
7087064 | Hyde | Aug 2006 | B1 |
7100614 | Stevens et al. | Sep 2006 | B2 |
7101395 | Tremulis et al. | Sep 2006 | B2 |
7108717 | Freidberg | Sep 2006 | B2 |
7112219 | Vidlund et al. | Sep 2006 | B2 |
7115141 | Menz et al. | Oct 2006 | B2 |
7141064 | Scott et al. | Nov 2006 | B2 |
7175656 | Khairkhahan | Feb 2007 | B2 |
7198646 | Figulla et al. | Apr 2007 | B2 |
7201772 | Schwammenthal et al. | Apr 2007 | B2 |
7247134 | Vidlund et al. | Jul 2007 | B2 |
7252682 | Seguin | Aug 2007 | B2 |
7267686 | DiMatteo et al. | Sep 2007 | B2 |
7275604 | Wall | Oct 2007 | B1 |
7276078 | Spenser et al. | Oct 2007 | B2 |
7276084 | Yang et al. | Oct 2007 | B2 |
7316706 | Bloom et al. | Jan 2008 | B2 |
7318278 | Zhang et al. | Jan 2008 | B2 |
7326236 | Andreas et al. | Feb 2008 | B2 |
7329278 | Seguin et al. | Feb 2008 | B2 |
7331991 | Kheradvar et al. | Feb 2008 | B2 |
7335213 | Hyde et al. | Feb 2008 | B1 |
7374571 | Pease et al. | May 2008 | B2 |
7377941 | Rhee et al. | May 2008 | B2 |
7381210 | Zarbatany et al. | Jun 2008 | B2 |
7381218 | Schreck | Jun 2008 | B2 |
7393360 | Spenser et al. | Jul 2008 | B2 |
7404824 | Webler et al. | Jul 2008 | B1 |
7416554 | Lam et al. | Aug 2008 | B2 |
7422072 | Dade | Sep 2008 | B2 |
7429269 | Schwammenthal et al. | Sep 2008 | B2 |
7442204 | Schwammenthal et al. | Oct 2008 | B2 |
7445631 | Salahieh et al. | Nov 2008 | B2 |
7462191 | Spenser et al. | Dec 2008 | B2 |
7470285 | Nugent et al. | Dec 2008 | B2 |
7500989 | Solem et al. | Mar 2009 | B2 |
7503931 | Kowalsky et al. | Mar 2009 | B2 |
7510572 | Gabbay | Mar 2009 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7513908 | Lattouf | Apr 2009 | B2 |
7524330 | Berreklouw | Apr 2009 | B2 |
7527647 | Spence | May 2009 | B2 |
7534260 | Lattouf | May 2009 | B2 |
7556646 | Yang et al. | Jul 2009 | B2 |
7579381 | Dove | Aug 2009 | B2 |
7585321 | Cribier | Sep 2009 | B2 |
7591847 | Navia et al. | Sep 2009 | B2 |
7618446 | Andersen et al. | Nov 2009 | B2 |
7618447 | Case et al. | Nov 2009 | B2 |
7621948 | Herrmann et al. | Nov 2009 | B2 |
7632304 | Park | Dec 2009 | B2 |
7632308 | Loulmet | Dec 2009 | B2 |
7635386 | Gammie | Dec 2009 | B1 |
7674222 | Nikolic et al. | Mar 2010 | B2 |
7674286 | Alfieri et al. | Mar 2010 | B2 |
7695510 | Bloom et al. | Apr 2010 | B2 |
7708775 | Rowe et al. | May 2010 | B2 |
7748389 | Salahieh et al. | Jul 2010 | B2 |
7766961 | Patel et al. | Aug 2010 | B2 |
7789909 | Andersen et al. | Sep 2010 | B2 |
7803168 | Gifford et al. | Sep 2010 | B2 |
7803184 | McGuckin, Jr. et al. | Sep 2010 | B2 |
7803185 | Gabbay | Sep 2010 | B2 |
7806928 | Rowe et al. | Oct 2010 | B2 |
7837727 | Goetz et al. | Nov 2010 | B2 |
7854762 | Speziali et al. | Dec 2010 | B2 |
7892281 | Seguin et al. | Feb 2011 | B2 |
7896915 | Guyenot et al. | Mar 2011 | B2 |
7901454 | Kapadia et al. | Mar 2011 | B2 |
7927370 | Webler et al. | Apr 2011 | B2 |
7931630 | Nishtala et al. | Apr 2011 | B2 |
7942928 | Webler et al. | May 2011 | B2 |
7955247 | Levine et al. | Jun 2011 | B2 |
7955385 | Crittenden | Jun 2011 | B2 |
7972378 | Tabor et al. | Jul 2011 | B2 |
7988727 | Santamore et al. | Aug 2011 | B2 |
7993394 | Hariton et al. | Aug 2011 | B2 |
8007992 | Tian et al. | Aug 2011 | B2 |
8029556 | Rowe | Oct 2011 | B2 |
8043368 | Crabtree | Oct 2011 | B2 |
8052749 | Salahieh et al. | Nov 2011 | B2 |
8052750 | Tuval et al. | Nov 2011 | B2 |
8052751 | Aklog et al. | Nov 2011 | B2 |
8062355 | Figulla et al. | Nov 2011 | B2 |
8062359 | Marquez et al. | Nov 2011 | B2 |
8070802 | Lamphere et al. | Dec 2011 | B2 |
8109996 | Stacchino et al. | Feb 2012 | B2 |
8142495 | Hasenkam et al. | Mar 2012 | B2 |
8152821 | Gambale et al. | Apr 2012 | B2 |
8157810 | Case et al. | Apr 2012 | B2 |
8167932 | Bourang et al. | May 2012 | B2 |
8167934 | Styrc et al. | May 2012 | B2 |
8187299 | Goldfarb et al. | May 2012 | B2 |
8206439 | Gomez Duran | Jun 2012 | B2 |
8216301 | Bonhoeffer et al. | Jul 2012 | B2 |
8226711 | Mortier et al. | Jul 2012 | B2 |
8236045 | Benichou et al. | Aug 2012 | B2 |
8241274 | Keogh et al. | Aug 2012 | B2 |
8252051 | Chau et al. | Aug 2012 | B2 |
8303653 | Bonhoeffer et al. | Nov 2012 | B2 |
8308796 | Lashinski et al. | Nov 2012 | B2 |
8323334 | Deem et al. | Dec 2012 | B2 |
8353955 | Styrc et al. | Jan 2013 | B2 |
RE44075 | Williamson et al. | Mar 2013 | E |
8449599 | Chau et al. | May 2013 | B2 |
8454656 | Tuval | Jun 2013 | B2 |
8470028 | Thornton et al. | Jun 2013 | B2 |
8480730 | Maurer et al. | Jul 2013 | B2 |
8486138 | Vesely | Jul 2013 | B2 |
8506623 | Wilson et al. | Aug 2013 | B2 |
8506624 | Vidlund et al. | Aug 2013 | B2 |
8578705 | Sindano et al. | Nov 2013 | B2 |
8579913 | Nielsen | Nov 2013 | B2 |
8591573 | Barone | Nov 2013 | B2 |
8591576 | Hasenkam et al. | Nov 2013 | B2 |
8597347 | Maurer et al. | Dec 2013 | B2 |
8685086 | Navia et al. | Apr 2014 | B2 |
8790394 | Miller et al. | Jul 2014 | B2 |
8845717 | Khairkhahan et al. | Sep 2014 | B2 |
8888843 | Khairkhahan et al. | Nov 2014 | B2 |
8900214 | Nance et al. | Dec 2014 | B2 |
8900295 | Migliazza et al. | Dec 2014 | B2 |
8926696 | Cabiri et al. | Jan 2015 | B2 |
8932342 | McHugo et al. | Jan 2015 | B2 |
8932348 | Solem et al. | Jan 2015 | B2 |
8945208 | Jimenez et al. | Feb 2015 | B2 |
8956407 | Macoviak et al. | Feb 2015 | B2 |
8979922 | Jayasinghe et al. | Mar 2015 | B2 |
8986376 | Solem | Mar 2015 | B2 |
9011522 | Annest | Apr 2015 | B2 |
9023099 | Duffy et al. | May 2015 | B2 |
9034032 | McLean et al. | May 2015 | B2 |
9034033 | McLean et al. | May 2015 | B2 |
9039757 | McLean et al. | May 2015 | B2 |
9039759 | Alkhatib et al. | May 2015 | B2 |
9078645 | Conklin et al. | Jul 2015 | B2 |
9078749 | Lutter et al. | Jul 2015 | B2 |
9084676 | Chau et al. | Jul 2015 | B2 |
9095433 | Lutter et al. | Aug 2015 | B2 |
9125742 | Yoganathan et al. | Sep 2015 | B2 |
9149357 | Seguin | Oct 2015 | B2 |
9161837 | Kapadia | Oct 2015 | B2 |
9168137 | Subramanian et al. | Oct 2015 | B2 |
9232995 | Kovalsky et al. | Jan 2016 | B2 |
9232998 | Wilson et al. | Jan 2016 | B2 |
9232999 | Maurer et al. | Jan 2016 | B2 |
9241702 | Maisano et al. | Jan 2016 | B2 |
9254192 | Lutter et al. | Feb 2016 | B2 |
9265608 | Miller et al. | Feb 2016 | B2 |
9289295 | Aklog et al. | Mar 2016 | B2 |
9289297 | Wilson et al. | Mar 2016 | B2 |
9345573 | Nyuli et al. | May 2016 | B2 |
9480557 | Pellegrini et al. | Nov 2016 | B2 |
9480559 | Vidlund et al. | Nov 2016 | B2 |
9526611 | Tegels et al. | Dec 2016 | B2 |
9597181 | Christianson et al. | Mar 2017 | B2 |
9610159 | Christianson et al. | Apr 2017 | B2 |
9675454 | Vidlund et al. | Jun 2017 | B2 |
9730792 | Lutter et al. | Aug 2017 | B2 |
9827092 | Vidlund et al. | Nov 2017 | B2 |
9833315 | Vidlund et al. | Dec 2017 | B2 |
9867700 | Bakis et al. | Jan 2018 | B2 |
9883941 | Hastings et al. | Feb 2018 | B2 |
9895221 | Vidlund | Feb 2018 | B2 |
9986993 | Vidlund et al. | Jun 2018 | B2 |
10327894 | Vidlund et al. | Jun 2019 | B2 |
20010018611 | Solem et al. | Aug 2001 | A1 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20010025171 | Mortier et al. | Sep 2001 | A1 |
20020010427 | Scarfone et al. | Jan 2002 | A1 |
20020116054 | Lundell et al. | Aug 2002 | A1 |
20020139056 | Finnell | Oct 2002 | A1 |
20020151961 | Lashinski et al. | Oct 2002 | A1 |
20020161377 | Rabkin | Oct 2002 | A1 |
20020173842 | Buchanan | Nov 2002 | A1 |
20020183827 | Derus et al. | Dec 2002 | A1 |
20030010509 | Hoffman | Jan 2003 | A1 |
20030036698 | Kohler et al. | Feb 2003 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030078652 | Sutherland | Apr 2003 | A1 |
20030100939 | Yodat et al. | May 2003 | A1 |
20030105519 | Fasol et al. | Jun 2003 | A1 |
20030105520 | Alferness et al. | Jun 2003 | A1 |
20030120340 | Liska et al. | Jun 2003 | A1 |
20030130731 | Vidlund et al. | Jul 2003 | A1 |
20030149476 | Damm et al. | Aug 2003 | A1 |
20030212454 | Scott et al. | Nov 2003 | A1 |
20040039436 | Spenser et al. | Feb 2004 | A1 |
20040049266 | Anduiza et al. | Mar 2004 | A1 |
20040064014 | Melvin et al. | Apr 2004 | A1 |
20040092858 | Wilson et al. | May 2004 | A1 |
20040093075 | Kuehne | May 2004 | A1 |
20040097865 | Anderson et al. | May 2004 | A1 |
20040127983 | Mortier et al. | Jul 2004 | A1 |
20040133263 | Dusbabek et al. | Jul 2004 | A1 |
20040147958 | Lam et al. | Jul 2004 | A1 |
20040152947 | Schroeder et al. | Aug 2004 | A1 |
20040162610 | Liska et al. | Aug 2004 | A1 |
20040163828 | Silverstein et al. | Aug 2004 | A1 |
20040181239 | Dorn et al. | Sep 2004 | A1 |
20040186565 | Schreck | Sep 2004 | A1 |
20040186566 | Hindrichs et al. | Sep 2004 | A1 |
20040260317 | Bloom et al. | Dec 2004 | A1 |
20040260389 | Case et al. | Dec 2004 | A1 |
20050004652 | van der Burg et al. | Jan 2005 | A1 |
20050004666 | Alfieri et al. | Jan 2005 | A1 |
20050075727 | Wheatley | Apr 2005 | A1 |
20050080402 | Santamore et al. | Apr 2005 | A1 |
20050085900 | Case et al. | Apr 2005 | A1 |
20050096498 | Houser et al. | May 2005 | A1 |
20050107661 | Lau et al. | May 2005 | A1 |
20050113798 | Slater et al. | May 2005 | A1 |
20050113810 | Houser et al. | May 2005 | A1 |
20050113811 | Houser et al. | May 2005 | A1 |
20050119519 | Girard et al. | Jun 2005 | A9 |
20050121206 | Dolan | Jun 2005 | A1 |
20050125012 | Houser et al. | Jun 2005 | A1 |
20050137686 | Salahieh et al. | Jun 2005 | A1 |
20050137688 | Salahieh et al. | Jun 2005 | A1 |
20050137695 | Salahieh et al. | Jun 2005 | A1 |
20050137698 | Salahieh et al. | Jun 2005 | A1 |
20050148815 | Mortier et al. | Jul 2005 | A1 |
20050177180 | Kaganov et al. | Aug 2005 | A1 |
20050197695 | Stacchino et al. | Sep 2005 | A1 |
20050203614 | Forster et al. | Sep 2005 | A1 |
20050203615 | Forster et al. | Sep 2005 | A1 |
20050203617 | Forster et al. | Sep 2005 | A1 |
20050234546 | Nugent et al. | Oct 2005 | A1 |
20050240200 | Bergheim | Oct 2005 | A1 |
20050251209 | Saadat et al. | Nov 2005 | A1 |
20050256567 | Lim et al. | Nov 2005 | A1 |
20050283231 | Haug et al. | Dec 2005 | A1 |
20050288766 | Plain et al. | Dec 2005 | A1 |
20060004442 | Spenser et al. | Jan 2006 | A1 |
20060025784 | Starksen et al. | Feb 2006 | A1 |
20060025857 | Bergheim et al. | Feb 2006 | A1 |
20060030885 | Hyde | Feb 2006 | A1 |
20060042803 | Gallaher | Mar 2006 | A1 |
20060047338 | Jenson et al. | Mar 2006 | A1 |
20060052868 | Mortier et al. | Mar 2006 | A1 |
20060058872 | Salahieh et al. | Mar 2006 | A1 |
20060094983 | Burbank et al. | May 2006 | A1 |
20060129025 | Levine et al. | Jun 2006 | A1 |
20060142784 | Kontos | Jun 2006 | A1 |
20060161040 | McCarthy et al. | Jul 2006 | A1 |
20060161249 | Realyvasquez et al. | Jul 2006 | A1 |
20060167541 | Lattouf | Jul 2006 | A1 |
20060195134 | Crittenden | Aug 2006 | A1 |
20060195183 | Navia et al. | Aug 2006 | A1 |
20060229708 | Powell et al. | Oct 2006 | A1 |
20060229719 | Marquez et al. | Oct 2006 | A1 |
20060241745 | Solem | Oct 2006 | A1 |
20060247491 | Vidlund et al. | Nov 2006 | A1 |
20060252984 | Rahdert et al. | Nov 2006 | A1 |
20060259135 | Navia et al. | Nov 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060259137 | Artof et al. | Nov 2006 | A1 |
20060276874 | Wilson et al. | Dec 2006 | A1 |
20060282161 | Huynh et al. | Dec 2006 | A1 |
20060287716 | Banbury et al. | Dec 2006 | A1 |
20060287717 | Rowe et al. | Dec 2006 | A1 |
20070005131 | Taylor | Jan 2007 | A1 |
20070005231 | Seguchi | Jan 2007 | A1 |
20070010877 | Salahieh et al. | Jan 2007 | A1 |
20070016286 | Herrmann et al. | Jan 2007 | A1 |
20070016288 | Gurskis et al. | Jan 2007 | A1 |
20070027535 | Purdy et al. | Feb 2007 | A1 |
20070038291 | Case et al. | Feb 2007 | A1 |
20070050020 | Spence | Mar 2007 | A1 |
20070061010 | Hauser et al. | Mar 2007 | A1 |
20070066863 | Rafiee et al. | Mar 2007 | A1 |
20070073387 | Forster et al. | Mar 2007 | A1 |
20070078297 | Rafiee et al. | Apr 2007 | A1 |
20070083076 | Lichtenstein | Apr 2007 | A1 |
20070083259 | Bloom et al. | Apr 2007 | A1 |
20070088431 | Bourang et al. | Apr 2007 | A1 |
20070093890 | Eliasen et al. | Apr 2007 | A1 |
20070100439 | Cangialosi et al. | May 2007 | A1 |
20070112355 | Salahieh et al. | May 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070112425 | Schaller et al. | May 2007 | A1 |
20070118151 | Davidson | May 2007 | A1 |
20070118154 | Crabtree | May 2007 | A1 |
20070118210 | Pinchuk | May 2007 | A1 |
20070118213 | Loulmet | May 2007 | A1 |
20070142906 | Figulla et al. | Jun 2007 | A1 |
20070161846 | Nikolic et al. | Jul 2007 | A1 |
20070162048 | Quinn et al. | Jul 2007 | A1 |
20070162103 | Case et al. | Jul 2007 | A1 |
20070168024 | Khairkhahan | Jul 2007 | A1 |
20070185565 | Schwammenthal et al. | Aug 2007 | A1 |
20070185571 | Kapadia et al. | Aug 2007 | A1 |
20070203575 | Forster et al. | Aug 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070215362 | Rodgers | Sep 2007 | A1 |
20070221388 | Johnson | Sep 2007 | A1 |
20070233239 | Navia et al. | Oct 2007 | A1 |
20070239265 | Birdsall | Oct 2007 | A1 |
20070256843 | Pahila | Nov 2007 | A1 |
20070265658 | Nelson et al. | Nov 2007 | A1 |
20070267202 | Mariller | Nov 2007 | A1 |
20070270932 | Headley et al. | Nov 2007 | A1 |
20070270943 | Solem et al. | Nov 2007 | A1 |
20070293944 | Spenser et al. | Dec 2007 | A1 |
20080009940 | Cribier | Jan 2008 | A1 |
20080033543 | Gurskis et al. | Feb 2008 | A1 |
20080065011 | Marchand et al. | Mar 2008 | A1 |
20080071361 | Tuval et al. | Mar 2008 | A1 |
20080071362 | Tuval et al. | Mar 2008 | A1 |
20080071363 | Tuval et al. | Mar 2008 | A1 |
20080071366 | Tuval et al. | Mar 2008 | A1 |
20080071368 | Tuval et al. | Mar 2008 | A1 |
20080071369 | Tuval et al. | Mar 2008 | A1 |
20080082163 | Woo | Apr 2008 | A1 |
20080082166 | Styrc et al. | Apr 2008 | A1 |
20080091264 | Machold et al. | Apr 2008 | A1 |
20080114442 | Mitchell et al. | May 2008 | A1 |
20080125861 | Webler et al. | May 2008 | A1 |
20080147179 | Cai et al. | Jun 2008 | A1 |
20080154355 | Benichou et al. | Jun 2008 | A1 |
20080154356 | Obermiller et al. | Jun 2008 | A1 |
20080161911 | Revuelta et al. | Jul 2008 | A1 |
20080172035 | Starksen et al. | Jul 2008 | A1 |
20080177381 | Navia et al. | Jul 2008 | A1 |
20080183203 | Fitzgerald et al. | Jul 2008 | A1 |
20080183273 | Mesana et al. | Jul 2008 | A1 |
20080188928 | Salahieh et al. | Aug 2008 | A1 |
20080195199 | Kheradvar et al. | Aug 2008 | A1 |
20080208328 | Antocci et al. | Aug 2008 | A1 |
20080208332 | Lamphere et al. | Aug 2008 | A1 |
20080221672 | Lamphere et al. | Sep 2008 | A1 |
20080243150 | Starksen et al. | Oct 2008 | A1 |
20080243245 | Thambar et al. | Oct 2008 | A1 |
20080255660 | Guyenot et al. | Oct 2008 | A1 |
20080255661 | Straubinger et al. | Oct 2008 | A1 |
20080281411 | Berreklouw | Nov 2008 | A1 |
20080288060 | Kaye et al. | Nov 2008 | A1 |
20080293996 | Evans et al. | Nov 2008 | A1 |
20090005863 | Goetz | Jan 2009 | A1 |
20090048668 | Wilson et al. | Feb 2009 | A1 |
20090054968 | Bonhoeffer et al. | Feb 2009 | A1 |
20090054974 | McGuckin, Jr. et al. | Feb 2009 | A1 |
20090062908 | Bonhoeffer et al. | Mar 2009 | A1 |
20090076598 | Salahieh et al. | Mar 2009 | A1 |
20090082619 | De Marchena | Mar 2009 | A1 |
20090088836 | Bishop et al. | Apr 2009 | A1 |
20090099410 | De Marchena | Apr 2009 | A1 |
20090112309 | Jaramillo et al. | Apr 2009 | A1 |
20090131849 | Maurer et al. | May 2009 | A1 |
20090132035 | Roth et al. | May 2009 | A1 |
20090137861 | Goldberg et al. | May 2009 | A1 |
20090138079 | Tuval et al. | May 2009 | A1 |
20090157175 | Benichou | Jun 2009 | A1 |
20090164005 | Dove et al. | Jun 2009 | A1 |
20090171432 | Von Segesser et al. | Jul 2009 | A1 |
20090171447 | Von Segesser et al. | Jul 2009 | A1 |
20090171456 | Kveen et al. | Jul 2009 | A1 |
20090177266 | Powell et al. | Jul 2009 | A1 |
20090192601 | Rafiee et al. | Jul 2009 | A1 |
20090210052 | Forster et al. | Aug 2009 | A1 |
20090216322 | Le et al. | Aug 2009 | A1 |
20090222076 | Figulla et al. | Sep 2009 | A1 |
20090224529 | Gill | Sep 2009 | A1 |
20090234318 | Loulmet et al. | Sep 2009 | A1 |
20090234435 | Johnson et al. | Sep 2009 | A1 |
20090234443 | Ottma et al. | Sep 2009 | A1 |
20090240320 | Tuval et al. | Sep 2009 | A1 |
20090248149 | Gabbay | Oct 2009 | A1 |
20090276040 | Rowe et al. | Nov 2009 | A1 |
20090281619 | Le et al. | Nov 2009 | A1 |
20090287299 | Tabor et al. | Nov 2009 | A1 |
20090292262 | Adams et al. | Nov 2009 | A1 |
20090319037 | Rowe et al. | Dec 2009 | A1 |
20090326575 | Galdonik et al. | Dec 2009 | A1 |
20100016958 | St. Goar et al. | Jan 2010 | A1 |
20100021382 | Dorshow et al. | Jan 2010 | A1 |
20100023117 | Yoganathan et al. | Jan 2010 | A1 |
20100036479 | Hill et al. | Feb 2010 | A1 |
20100049313 | Alon et al. | Feb 2010 | A1 |
20100082094 | Quadri et al. | Apr 2010 | A1 |
20100161041 | Maisano et al. | Jun 2010 | A1 |
20100168839 | Braido et al. | Jul 2010 | A1 |
20100179641 | Ryan et al. | Jul 2010 | A1 |
20100185277 | Braido et al. | Jul 2010 | A1 |
20100185278 | Schankereli | Jul 2010 | A1 |
20100191326 | Alkhatib | Jul 2010 | A1 |
20100192402 | Yamaguchi et al. | Aug 2010 | A1 |
20100204781 | Alkhatib | Aug 2010 | A1 |
20100210899 | Schankereli | Aug 2010 | A1 |
20100217382 | Chau et al. | Aug 2010 | A1 |
20100249489 | Jarvik | Sep 2010 | A1 |
20100249923 | Alkhatib et al. | Sep 2010 | A1 |
20100256754 | Styrc | Oct 2010 | A1 |
20100280589 | Styrc | Nov 2010 | A1 |
20100280604 | Zipory et al. | Nov 2010 | A1 |
20100286768 | Alkhatib | Nov 2010 | A1 |
20100298755 | McNamara et al. | Nov 2010 | A1 |
20100298931 | Quadri et al. | Nov 2010 | A1 |
20110004296 | Lutter et al. | Jan 2011 | A1 |
20110015616 | Straubinger et al. | Jan 2011 | A1 |
20110015728 | Jimenez et al. | Jan 2011 | A1 |
20110015729 | Jimenez et al. | Jan 2011 | A1 |
20110029072 | Gabbay | Feb 2011 | A1 |
20110066231 | Cartledge et al. | Mar 2011 | A1 |
20110066233 | Thornton et al. | Mar 2011 | A1 |
20110112632 | Chau et al. | May 2011 | A1 |
20110137397 | Chau et al. | Jun 2011 | A1 |
20110137408 | Bergheim | Jun 2011 | A1 |
20110208283 | Rust | Aug 2011 | A1 |
20110218619 | Benichou et al. | Sep 2011 | A1 |
20110224655 | Asirvatham et al. | Sep 2011 | A1 |
20110224678 | Gabbay | Sep 2011 | A1 |
20110224728 | Martin et al. | Sep 2011 | A1 |
20110224784 | Quinn | Sep 2011 | A1 |
20110245911 | Quill et al. | Oct 2011 | A1 |
20110251682 | Murray, III et al. | Oct 2011 | A1 |
20110264191 | Rothstein | Oct 2011 | A1 |
20110264206 | Tabor | Oct 2011 | A1 |
20110288637 | De Marchena | Nov 2011 | A1 |
20110319988 | Schankereli et al. | Dec 2011 | A1 |
20110319989 | Lane et al. | Dec 2011 | A1 |
20120010694 | Lutter et al. | Jan 2012 | A1 |
20120016468 | Robin et al. | Jan 2012 | A1 |
20120022640 | Gross et al. | Jan 2012 | A1 |
20120035703 | Lutter et al. | Feb 2012 | A1 |
20120035713 | Lutter et al. | Feb 2012 | A1 |
20120035722 | Tuval | Feb 2012 | A1 |
20120053686 | McNamara et al. | Mar 2012 | A1 |
20120059487 | Cunanan et al. | Mar 2012 | A1 |
20120089171 | Hastings et al. | Apr 2012 | A1 |
20120101571 | Thambar et al. | Apr 2012 | A1 |
20120101572 | Kovalsky et al. | Apr 2012 | A1 |
20120116351 | Chomas et al. | May 2012 | A1 |
20120123529 | Levi et al. | May 2012 | A1 |
20120165930 | Gifford, III et al. | Jun 2012 | A1 |
20120179244 | Schankereli et al. | Jul 2012 | A1 |
20120203336 | Annest | Aug 2012 | A1 |
20120215303 | Quadri et al. | Aug 2012 | A1 |
20120226348 | Lane et al. | Sep 2012 | A1 |
20120283824 | Lutter et al. | Nov 2012 | A1 |
20120289945 | Segermark | Nov 2012 | A1 |
20130030522 | Rowe et al. | Jan 2013 | A1 |
20130053950 | Rowe et al. | Feb 2013 | A1 |
20130066341 | Ketai et al. | Mar 2013 | A1 |
20130079873 | Migliazza et al. | Mar 2013 | A1 |
20130123898 | Tung et al. | May 2013 | A1 |
20130131788 | Quadri et al. | May 2013 | A1 |
20130172978 | Vidlund et al. | Jul 2013 | A1 |
20130184811 | Rowe et al. | Jul 2013 | A1 |
20130190860 | Sundt, III | Jul 2013 | A1 |
20130190861 | Chau et al. | Jul 2013 | A1 |
20130197622 | Mitra et al. | Aug 2013 | A1 |
20130197629 | Gainor et al. | Aug 2013 | A1 |
20130226288 | Goldwasser et al. | Aug 2013 | A1 |
20130231735 | Deem et al. | Sep 2013 | A1 |
20130274874 | Hammer | Oct 2013 | A1 |
20130282101 | Eidenschink et al. | Oct 2013 | A1 |
20130310928 | Morriss et al. | Nov 2013 | A1 |
20130317603 | McLean et al. | Nov 2013 | A1 |
20130325041 | Annest et al. | Dec 2013 | A1 |
20130325110 | Khalil et al. | Dec 2013 | A1 |
20130338752 | Geusen et al. | Dec 2013 | A1 |
20140046433 | Kovalsky | Feb 2014 | A1 |
20140081323 | Hawkins | Mar 2014 | A1 |
20140094918 | Vishnubholta et al. | Apr 2014 | A1 |
20140142691 | Pouletty | May 2014 | A1 |
20140163668 | Rafiee | Jun 2014 | A1 |
20140194981 | Menk et al. | Jul 2014 | A1 |
20140194983 | Kovalsky et al. | Jul 2014 | A1 |
20140214159 | Vidlund et al. | Jul 2014 | A1 |
20140222142 | Kovalsky et al. | Aug 2014 | A1 |
20140243965 | Benson | Aug 2014 | A1 |
20140243966 | Garde et al. | Aug 2014 | A1 |
20140277419 | Garde et al. | Sep 2014 | A1 |
20140288639 | Gainor | Sep 2014 | A1 |
20140296969 | Tegels et al. | Oct 2014 | A1 |
20140296970 | Ekvall et al. | Oct 2014 | A1 |
20140296971 | Tegels et al. | Oct 2014 | A1 |
20140296972 | Tegels et al. | Oct 2014 | A1 |
20140296975 | Tegels et al. | Oct 2014 | A1 |
20140303718 | Tegels et al. | Oct 2014 | A1 |
20140309732 | Solem | Oct 2014 | A1 |
20140316516 | Vidlund et al. | Oct 2014 | A1 |
20140324160 | Benichou et al. | Oct 2014 | A1 |
20140324161 | Tegels et al. | Oct 2014 | A1 |
20140324164 | Gross et al. | Oct 2014 | A1 |
20140331475 | Duffy et al. | Nov 2014 | A1 |
20140343670 | Bakis et al. | Nov 2014 | A1 |
20140358224 | Tegels et al. | Dec 2014 | A1 |
20140364942 | Straubinger et al. | Dec 2014 | A1 |
20140364944 | Lutter et al. | Dec 2014 | A1 |
20140371844 | Dale | Dec 2014 | A1 |
20140379076 | Vidlund et al. | Dec 2014 | A1 |
20150005874 | Vidlund et al. | Jan 2015 | A1 |
20150011821 | Gorman et al. | Jan 2015 | A1 |
20150025553 | Del Nido et al. | Jan 2015 | A1 |
20150057705 | Vidlund | Feb 2015 | A1 |
20150073542 | Heldman | Mar 2015 | A1 |
20150073545 | Braido | Mar 2015 | A1 |
20150094802 | Buchbinder et al. | Apr 2015 | A1 |
20150105856 | Rowe et al. | Apr 2015 | A1 |
20150119936 | Gilmore et al. | Apr 2015 | A1 |
20150119978 | Tegels et al. | Apr 2015 | A1 |
20150127093 | Hosmer et al. | May 2015 | A1 |
20150127096 | Rowe et al. | May 2015 | A1 |
20150134050 | Solem et al. | May 2015 | A1 |
20150142100 | Morriss et al. | May 2015 | A1 |
20150142101 | Coleman et al. | May 2015 | A1 |
20150142103 | Vidlund | May 2015 | A1 |
20150142104 | Braido | May 2015 | A1 |
20150173897 | Raanani et al. | Jun 2015 | A1 |
20150196393 | Vidlund et al. | Jul 2015 | A1 |
20150196688 | James | Jul 2015 | A1 |
20150202044 | Chau et al. | Jul 2015 | A1 |
20150216653 | Freudenthal | Aug 2015 | A1 |
20150216660 | Pintor | Aug 2015 | A1 |
20150223820 | Olson | Aug 2015 | A1 |
20150223934 | Vidlund et al. | Aug 2015 | A1 |
20150238312 | Lashinski | Aug 2015 | A1 |
20150238729 | Jenson et al. | Aug 2015 | A1 |
20150272731 | Racchini et al. | Oct 2015 | A1 |
20150305860 | Wang et al. | Oct 2015 | A1 |
20150305864 | Quadri et al. | Oct 2015 | A1 |
20150305868 | Lutter et al. | Oct 2015 | A1 |
20150327995 | Morin et al. | Nov 2015 | A1 |
20150328001 | McLean | Nov 2015 | A1 |
20150335424 | McLean | Nov 2015 | A1 |
20150335429 | Morriss et al. | Nov 2015 | A1 |
20150342717 | O'Donnell et al. | Dec 2015 | A1 |
20150351903 | Morriss et al. | Dec 2015 | A1 |
20150351906 | Hammer et al. | Dec 2015 | A1 |
20160000562 | Siegel | Jan 2016 | A1 |
20160008131 | Christianson et al. | Jan 2016 | A1 |
20160067042 | Murad et al. | Mar 2016 | A1 |
20160074160 | Christianson et al. | Mar 2016 | A1 |
20160106537 | Christianson et al. | Apr 2016 | A1 |
20160113764 | Sheahan | Apr 2016 | A1 |
20160143736 | Vidlund et al. | May 2016 | A1 |
20160151155 | Lutter et al. | Jun 2016 | A1 |
20160206280 | Vidlund et al. | Jul 2016 | A1 |
20160242902 | Morriss | Aug 2016 | A1 |
20160262879 | Meiri et al. | Sep 2016 | A1 |
20160262881 | Schankereli et al. | Sep 2016 | A1 |
20160278955 | Liu et al. | Sep 2016 | A1 |
20160317290 | Chau | Nov 2016 | A1 |
20160324635 | Vidlund et al. | Nov 2016 | A1 |
20160331527 | Vidlund et al. | Nov 2016 | A1 |
20160346086 | Solem | Dec 2016 | A1 |
20160367365 | Conklin | Dec 2016 | A1 |
20160367367 | Maisano et al. | Dec 2016 | A1 |
20160367368 | Vidlund et al. | Dec 2016 | A1 |
20170007970 | Baruch et al. | Jan 2017 | A1 |
20170100248 | Tegels et al. | Apr 2017 | A1 |
20170128208 | Christianson et al. | May 2017 | A1 |
20170181854 | Christianson et al. | Jun 2017 | A1 |
20170189174 | Braido et al. | Jul 2017 | A1 |
20170196688 | Christianson et al. | Jul 2017 | A1 |
20170252153 | Chau et al. | Sep 2017 | A1 |
20170266001 | Vidlund et al. | Sep 2017 | A1 |
20170281343 | Christianson et al. | Oct 2017 | A1 |
20170312076 | Lutter et al. | Nov 2017 | A1 |
20170312077 | Vidlund et al. | Nov 2017 | A1 |
20170319333 | Tegels et al. | Nov 2017 | A1 |
20170325955 | Richter et al. | Nov 2017 | A1 |
20180028314 | Ekvall et al. | Feb 2018 | A1 |
20180078368 | Vidlund et al. | Mar 2018 | A1 |
20180078370 | Kovalsky et al. | Mar 2018 | A1 |
20180147055 | Vidlund et al. | May 2018 | A1 |
Number | Date | Country |
---|---|---|
1486161 | Mar 2004 | CN |
1961845 | May 2007 | CN |
2902226 | May 2007 | CN |
101146484 | Mar 2008 | CN |
101180010 | May 2008 | CN |
101686858 | Mar 2010 | CN |
101861134 | Oct 2010 | CN |
101180010 | Dec 2010 | CN |
101984938 | Mar 2011 | CN |
102639179 | Aug 2012 | CN |
102791223 | Nov 2012 | CN |
102858276 | Jan 2013 | CN |
102869317 | Jan 2013 | CN |
102869318 | Jan 2013 | CN |
102869321 | Jan 2013 | CN |
103220993 | Jul 2013 | CN |
103826569 | May 2014 | CN |
103974674 | Aug 2014 | CN |
104055602 | Sep 2014 | CN |
105188612 | Dec 2015 | CN |
105208973 | Dec 2015 | CN |
2246526 | Mar 1973 | DE |
19532846 | Mar 1997 | DE |
19546692 | Jun 1997 | DE |
19857887 | Jul 2000 | DE |
19907646 | Aug 2000 | DE |
10049812 | Apr 2002 | DE |
10049813 | Apr 2002 | DE |
10049815 | Apr 2002 | DE |
102006052564 | Dec 2007 | DE |
102006052710 | May 2008 | DE |
102007043830 | Apr 2009 | DE |
102007043831 | Apr 2009 | DE |
0103546 | Mar 1984 | EP |
1057460 | Dec 2000 | EP |
1088529 | Apr 2001 | EP |
1469797 | Oct 2004 | EP |
1469797 | Nov 2005 | EP |
2111800 | Oct 2009 | EP |
2193762 | Jun 2010 | EP |
2278944 | Feb 2011 | EP |
2747707 | Jul 2014 | EP |
2918248 | Sep 2015 | EP |
2788217 | Jul 2000 | FR |
2815844 | May 2002 | FR |
2003505146 | Feb 2003 | JP |
2005515836 | Jun 2005 | JP |
2009514628 | Apr 2009 | JP |
2009519783 | May 2009 | JP |
2009530070 | Aug 2009 | JP |
2010518947 | Jun 2010 | JP |
2013512765 | Apr 2013 | JP |
2014524760 | Sep 2014 | JP |
2014533190 | Dec 2014 | JP |
1017275 | Aug 2002 | NL |
1271508 | Nov 1986 | SU |
9217118 | Oct 1992 | WO |
9301768 | Feb 1993 | WO |
9829057 | Jul 1998 | WO |
9940964 | Aug 1999 | WO |
9947075 | Sep 1999 | WO |
2000018333 | Apr 2000 | WO |
2000030550 | Jun 2000 | WO |
200041652 | Jul 2000 | WO |
200047139 | Aug 2000 | WO |
2001035878 | May 2001 | WO |
2001049213 | Jul 2001 | WO |
0154625 | Aug 2001 | WO |
2001054624 | Aug 2001 | WO |
2001056512 | Aug 2001 | WO |
2001061289 | Aug 2001 | WO |
0176510 | Oct 2001 | WO |
200176510 | Oct 2001 | WO |
0182840 | Nov 2001 | WO |
2001082840 | Nov 2001 | WO |
2002004757 | Jan 2002 | WO |
0222054 | Mar 2002 | WO |
2002022054 | Mar 2002 | WO |
2002028321 | Apr 2002 | WO |
0236048 | May 2002 | WO |
2002041789 | May 2002 | WO |
0243620 | Jun 2002 | WO |
0249540 | Jun 2002 | WO |
2002043620 | Jun 2002 | WO |
2002049540 | Jun 2002 | WO |
02076348 | Oct 2002 | WO |
2003003943 | Jan 2003 | WO |
2003030776 | Apr 2003 | WO |
2003047468 | Jun 2003 | WO |
2003049619 | Jun 2003 | WO |
2004019825 | Mar 2004 | WO |
2005102181 | Nov 2005 | WO |
2006014233 | Feb 2006 | WO |
2006034008 | Mar 2006 | WO |
2006064490 | Jun 2006 | WO |
2006070372 | Jul 2006 | WO |
2006105009 | Oct 2006 | WO |
2006113906 | Oct 2006 | WO |
2006127756 | Nov 2006 | WO |
2007081412 | Jul 2007 | WO |
2007100408 | Sep 2007 | WO |
2008005405 | Jan 2008 | WO |
2008035337 | Mar 2008 | WO |
2008091515 | Jul 2008 | WO |
2008125906 | Oct 2008 | WO |
2008147964 | Dec 2008 | WO |
2009024859 | Feb 2009 | WO |
2009026563 | Feb 2009 | WO |
2009045338 | Apr 2009 | WO |
2009132187 | Oct 2009 | WO |
2010090878 | Aug 2010 | WO |
2010098857 | Sep 2010 | WO |
2010121076 | Oct 2010 | WO |
2011017440 | Feb 2011 | WO |
2011022658 | Feb 2011 | WO |
2011069048 | Jun 2011 | WO |
2011072084 | Jun 2011 | WO |
2011106735 | Sep 2011 | WO |
2011109813 | Sep 2011 | WO |
2011159342 | Dec 2011 | WO |
2011163275 | Dec 2011 | WO |
2012027487 | Mar 2012 | WO |
2012036742 | Mar 2012 | WO |
2012095116 | Jul 2012 | WO |
2012158837 | Nov 2012 | WO |
2012177942 | Dec 2012 | WO |
2013028387 | Feb 2013 | WO |
2013045262 | Apr 2013 | WO |
2013059747 | Apr 2013 | WO |
2013028387 | May 2013 | WO |
2013096411 | Jun 2013 | WO |
2013175468 | Nov 2013 | WO |
2014121280 | Aug 2014 | WO |
2014144937 | Sep 2014 | WO |
2014162306 | Oct 2014 | WO |
2014189974 | Nov 2014 | WO |
2014210124 | Dec 2014 | WO |
2015051430 | Apr 2015 | WO |
2015058039 | Apr 2015 | WO |
2015063580 | May 2015 | WO |
2015065646 | May 2015 | WO |
2015120122 | Aug 2015 | WO |
2015138306 | Sep 2015 | WO |
2015173609 | Nov 2015 | WO |
2016112085 | Jul 2016 | WO |
2016126942 | Aug 2016 | WO |
2016168609 | Oct 2016 | WO |
2016196933 | Dec 2016 | WO |
2017096157 | Jun 2017 | WO |
2017132008 | Aug 2017 | WO |
2017218375 | Dec 2017 | WO |
2018005779 | Jan 2018 | WO |
2018013515 | Jan 2018 | WO |
Entry |
---|
US 9,155,620 B2, 10/2015, Gross et al. (withdrawn) |
International Search Report (dated Sep. 20, 2017). |
Al Zaibag, Muayed, et al., “Percutaneous Balloon Valvotomy in Tricuspid Stenos's,” British Heart Journal, Jan. 1987, vol. 57, No. 1, pp. 51-53. |
Al-Khaja, N. et al., “Eleven Years' Experience with Carpentier-Edwards Biological Valves in Relation to Survival and Complications,” European Journal of Cardiothoracic Surgery, Jun. 30, 1989, 3:305-311. |
Almagor, Y. et al., “Balloon Expandable Stent Implantation in Stenotic Right Heart Valved Conduits,” Journal of the American College of Cardiology, Nov. 1, 1990, 16(6):1310-1314. |
H. R. Andersen et al., “Transluminal Implantation of Artificial Heart Valves: Description of a New Expandable Aortic Valve and Initial Results with Implantation by Catheter Technique in Closed Chest Pigs,” European Heart Journal, 1992, Issue 5, vol. 13, pp. 704-708. |
Andersen, H. R., “History of Percutaneous Aortic Valve Prosthesis,” Herz, Aug. 2009, 34(5):343-346. |
Andersen, H. R., “Transluminal catheter implanted prosthetic heart valves,” International Journal of Angiology, 1998, 7(2):102-106. |
Robert C. Ashton Jr., “Development of an Intraluminal Device for the Treatment of Aortic Regurgitation: Prototype and in Vitro Testing System,” Journal of Thoracic and Cardiovascular Surgery, 1996, Issue/vol. 112, pp. 979-983. |
Benchimol, A. et al., “Simultaneous Left Ventricular Echocardiography and Aortic Blood Velocity During Rapid Right Ventricular Pacing in Man,” The American Journal of the Medical Sciences, Jan.-Feb. 1977, 273(1):55-62. |
G. M. Bernacca, et al., “Polyurethane Heart Valves: Fatigue Failure, Calcification, and Polyurethane Structure,” Journal of Biomedical Materials Research, Mar. 5, 1997, Issue 3, vol. 34, pp. 371-379. |
Boudjemline, Y. et al., “Steps Toward the Percutaneous Replacement of Atrioventricular Valves: An Experimental Study,” Journal of the American College of Cardiology, Jul. 2005, 46(2):360-365. |
Buckberg, G. et al., “Restoring Papillary Muscle Dimensions During Restoration In Dilated Hearts,” Interactive Cardiovascular and Thoracic Surgery, 2005, 4:475-477. |
Chamberlain, G., “Ceramics Replace Body Parts,” Design News, Jun. 9, 1997, Issue 11, vol. 52, 5 pages. |
Choo, S. J. et al., “Aortic Root Geometry: Pattern of Differences Between Leaflets and Sinuses of Valsava,” The Journal of Heart Valve Disease, Jul. 1999, 8:407-415. |
Declaration of Malcolm J. R. Dalrymple-Hay, Nov. 9, 2012, pp. 1-11; with Curriculum Vitae, Oct. 4, 2012. |
Dotter, C. T. et al., “Transluminal Treatment of Arteriosclerotic Obstruction. Description of a New Technic and a Preliminary Report of its Application,” Circulation, Nov. 1964, 30:654-670. |
Drawbaugh, K., “Feature—Heart Surgeons Explore Minimally Invasive Methods,” Reuters Limited, Jul. 16, 1996, 3 pages. |
Gray, H., The Aorta, Anatomy of the Human Body, 1918, Retrieved from the Internet <http://www.bartleby.com/107/142.html>, Dec. 10, 2012, 5 pages. |
Gray, H., The Heart, Anatomy of the Human Body, 1918, Retrieved from the Internet <http://education.yahoo.com/reference/gray/subjects/subject/138>, Aug. 10, 2012, 9 pages. |
Greenhalgh, E. S., “Design and characterization of a biomimetic prosthetic aortic heart valve,” 1994, ProQuest Dissertations and Theses, Department of Fiber and Polymer Science, North Carolina State University at Raleigh, 159 pages. |
Inoue, K. et al., “Clinical Application of Transvenous Mitral Commissurotomy by a New Balloon Catheter,” The Journal of Thoracic and Cardiovascular Surgery, 1984, 87:394-402. |
Jin, X. Y. et al., “Aortic Root Geometry and Stentless Porcine Valve Competence,” Seminars in Thoracic and Cardiovascular Surgery, Oct. 1999, 11(4):145-150. |
Knudsen, L. L. et al., “Catheter-implanted prosthetic heart valves. Transluminal catheter implantation of a new expandable artificial heart valve in the descending thoracic aorta in isolated vessels and closed chest pigs,” The International Journal of Artificial Organs, 1993, 16(5):253-262. |
Kolata, G., “Device That Opens Clogged Arteries Gets a Failing Grade in a New Study,” New York Times [online], <http://www.nytimes.com/1991/01/03/health/device-that-opens-clogged-ar-teries-gets-a-faili . . . ,>, published Jan. 3, 1991,retrieved from the Internet on Feb. 5, 2016, 3 pages. |
Lawrence, D. D., “Percutaneous Endovascular Graft: Experimental Evaluation,” Radiology, 1987, 163:357-360. |
Lozonschi, L., et al. “Transapical mitral valved stent implantation: A survival series in swine,” The Journal of Thoracic and Cardiovascular Surgery, 140(2):422-426 (Aug. 2010) published online Mar. 12, 2010, 1 page. |
Lutter, Georg, et al., Mitral valved stent implantation, European Journal of Cardio-Thoracic Surgery, 2010, vol. 38, pp. 350-355. |
Ma, L. et al., “Double-crowned valved stents for off-pump mitral valve replacement,” European Journal of Cardio-Thoracic Surgery, Aug. 2005, 28(2): 194-198. |
Moazami, N. et al., “Transluminal aortic valve placement: A feasibility study with a newly designed collapsible aortic valve,” ASAIO Journal, Sep./ Oct. 1996, 42(5):M381-M385. |
Orton, C., “Mitralseal: Hybrid Transcatheter Mitral Valve Replacement,” Symposium: Small Animal Proceedings, 2011, pp. 311-312. |
Pavcnik, M.D., Ph.D., Dusan, et al. “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Cardiovascular Radiology 1992; 183:151-154. |
Porstmann, W. et al., “Der Verschluß des Ductus Arteriosus Persistens ohne Thorakotomie,” Thoraxchirurgie Vaskuläre Chirurgie, Band 15, Heft 2, Stuttgart, Apr. 1967, pp. 199-203. |
Rashkind, W. J., “Creation of an Atrial Septal Defect Without Thoracotomy,” The Journal of the American Medical Association, Jun. 13, 1966, 196( 11 ): 173-174. |
Rashkind, W. J., “Historical Aspects of Interventional Cardiology: Past, Present, Future,” Texas Heart Institute Journal, Dec. 1986, 13(4):363-367. |
Reul, H. et al., “The Geomety of the Aortic Root in Health, at Valve Disease and After Valve Replacement,” J. Biomechanics, 1990, 23(2):181-191. |
Rosch, J. et al., “The Birth, Early Years and Future of Interventional Radiology,” J Vasc Interv Radiol., Jul. 2003, 4:841-853. |
Ross, D. N., “Aortic Valve Surgery,” Guy's Hospital, London, 1968, pp. 192-197. |
Rousseau, E. P. M. et al., “A Mechanical Analysis of the Closed Hancock Heart Valve Prosthesis,” Journal of Biomechanics, 1998, 21(7):545-562. |
Sabbah, A. N. et al., “Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: An Overview,” Dec. 1989, Journal of Cardiac Surgery, 4(4):302-309. |
Selby, M.D., J. Bayne, “Experience with New Retrieval Forceps for Foreign Body Removal in the Vascular, Urinary, and Biliary Systems,” Radiology 1990; 176:535-538. |
Serruys, P.W., et al., “Stenting of Coronary Arteries. Are we the Sorcerer's Apprentice?,” European Heart Journal (1989) 10, 774-782, pp. 37-45, Jun. 13, 1989. |
“Shape Memory Alloys,” Retrieved from the Internet: <http://webdocs.cs.ualberta.ca/.about.database/MEMS/sma.html>, Nov. 14, 2012, 3 pages. |
Sigwart, U., “An Overview of Intravascular Stents: Old and New,” Chapter 48, Interventional Cardiology, 2nd Edition, W.B. Saunders Company, Philadelphia, PA, © 1994, 1990, pp. 803-815. |
Tofeig, M. et al., “Transcatheter Closure of a Mid-Muscular Ventricular Septal Defect with an Amplatzer VSD Occluder Device,” Heart, 1999, 81:438-440. |
Uchida, Barry T., et al., “Modifications of Gianturco Expandable Wire Stents,” AJR:150, May 1988, Dec. 3, 1987, pp. 1185-1187. |
Watt, A.H., et al. “Intravenous Adenosine in the Treatment of Supraventricular Tachycardia; a Dose-Ranging Study and Interaction with Dipyridamole,” British Journal of Clinical Pharmacology (1986), 21, pp. 227-230. |
Webb, J. G. et al., “Percutaneous Aortic Valve Implantation Retrograde from the Femoral Artery,” Circulation, 2006, 113:842-850. |
Wheatley, M.D., David J., “Valve Prostheses,” Rob & Smith's Operative Surgery, Fourth Edition, pp. 415-424, ButtenNorths 1986. |
Yoganathan, A. P. et al., “The Current Status of Prosthetic Heart Valves,” In Polymetric Materials and Artificial Organs, Mar. 20, 1983, pp. 111-150, American Chemical Society. |
Search Report from 1st Chinese Office Action for Application No. 201780052626.9 dated Jun. 2, 2020; 4 pages. |
Bernacca, G. M. et al., “Polyurethane heart valves: Fatigue failure, calcification, and polyurethane structure,” Journal of Biomedical Materials Research, Mar. 5, 1997, 34(3):371-379. |
Uchida, B. T. et al., “Modifications of Gianturco Expandable Wire Stents,” Am. J. Roentgenol., May 1988, 150 (5):1185-1187. |
Number | Date | Country | |
---|---|---|---|
20210259837 A1 | Aug 2021 | US |
Number | Date | Country | |
---|---|---|---|
62356828 | Jun 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16310661 | US | |
Child | 17319136 | US |